US20180263642A1 - Methods and Devices for Removal of Thromboembolic Material - Google Patents
Methods and Devices for Removal of Thromboembolic Material Download PDFInfo
- Publication number
- US20180263642A1 US20180263642A1 US15/985,044 US201815985044A US2018263642A1 US 20180263642 A1 US20180263642 A1 US 20180263642A1 US 201815985044 A US201815985044 A US 201815985044A US 2018263642 A1 US2018263642 A1 US 2018263642A1
- Authority
- US
- United States
- Prior art keywords
- rotational member
- aspiration catheter
- aspiration
- catheter
- distal end
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000009424 thromboembolic effect Effects 0.000 title claims abstract description 87
- 239000000463 material Substances 0.000 title claims abstract description 83
- 238000000034 method Methods 0.000 title claims abstract description 60
- 238000000605 extraction Methods 0.000 claims abstract description 60
- 238000013459 approach Methods 0.000 claims description 24
- 210000001367 artery Anatomy 0.000 claims description 10
- 230000003213 activating effect Effects 0.000 claims description 8
- 230000017531 blood circulation Effects 0.000 claims description 6
- 230000008859 change Effects 0.000 claims description 6
- 239000012530 fluid Substances 0.000 claims description 6
- 238000012800 visualization Methods 0.000 claims description 5
- 238000003384 imaging method Methods 0.000 claims description 4
- 238000004891 communication Methods 0.000 claims description 3
- 238000005259 measurement Methods 0.000 claims description 3
- 210000003462 vein Anatomy 0.000 claims description 3
- 208000002847 Surgical Wound Diseases 0.000 claims description 2
- 206010003504 Aspiration Diseases 0.000 description 210
- 208000007536 Thrombosis Diseases 0.000 description 30
- 230000033001 locomotion Effects 0.000 description 18
- 208000032382 Ischaemic stroke Diseases 0.000 description 12
- 229920000642 polymer Polymers 0.000 description 12
- 239000003550 marker Substances 0.000 description 10
- 229910052751 metal Inorganic materials 0.000 description 10
- 239000002184 metal Substances 0.000 description 10
- 210000004556 brain Anatomy 0.000 description 9
- 238000001816 cooling Methods 0.000 description 9
- 230000010349 pulsation Effects 0.000 description 8
- 230000007704 transition Effects 0.000 description 8
- 208000032843 Hemorrhage Diseases 0.000 description 7
- 208000020658 intracerebral hemorrhage Diseases 0.000 description 7
- 230000000740 bleeding effect Effects 0.000 description 6
- 210000001627 cerebral artery Anatomy 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 230000036961 partial effect Effects 0.000 description 6
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 5
- 208000006011 Stroke Diseases 0.000 description 5
- 238000010276 construction Methods 0.000 description 5
- 230000002631 hypothermal effect Effects 0.000 description 5
- 210000003484 anatomy Anatomy 0.000 description 4
- 238000005452 bending Methods 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 210000004204 blood vessel Anatomy 0.000 description 4
- 230000002490 cerebral effect Effects 0.000 description 4
- 238000002591 computed tomography Methods 0.000 description 4
- 230000007246 mechanism Effects 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 230000003068 static effect Effects 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 208000001435 Thromboembolism Diseases 0.000 description 3
- 230000002457 bidirectional effect Effects 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- 238000002788 crimping Methods 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000034994 death Effects 0.000 description 3
- 238000002595 magnetic resonance imaging Methods 0.000 description 3
- 210000003657 middle cerebral artery Anatomy 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 230000000414 obstructive effect Effects 0.000 description 3
- 230000002093 peripheral effect Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 238000005476 soldering Methods 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 229960000103 thrombolytic agent Drugs 0.000 description 3
- 238000003466 welding Methods 0.000 description 3
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- 208000037260 Atherosclerotic Plaque Diseases 0.000 description 2
- 206010016717 Fistula Diseases 0.000 description 2
- 206010018985 Haemorrhage intracranial Diseases 0.000 description 2
- 208000016988 Hemorrhagic Stroke Diseases 0.000 description 2
- 208000008574 Intracranial Hemorrhages Diseases 0.000 description 2
- 102000003978 Tissue Plasminogen Activator Human genes 0.000 description 2
- 108090000373 Tissue Plasminogen Activator Proteins 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 229940127218 antiplatelet drug Drugs 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 210000005013 brain tissue Anatomy 0.000 description 2
- 239000003638 chemical reducing agent Substances 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000003527 fibrinolytic agent Substances 0.000 description 2
- 230000003890 fistula Effects 0.000 description 2
- 238000011010 flushing procedure Methods 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 230000000302 ischemic effect Effects 0.000 description 2
- 229910001092 metal group alloy Inorganic materials 0.000 description 2
- 238000012014 optical coherence tomography Methods 0.000 description 2
- 239000000106 platelet aggregation inhibitor Substances 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 238000013151 thrombectomy Methods 0.000 description 2
- 229960000187 tissue plasminogen activator Drugs 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 238000002604 ultrasonography Methods 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- 210000005166 vasculature Anatomy 0.000 description 2
- 208000004043 venous thromboembolism Diseases 0.000 description 2
- 200000000007 Arterial disease Diseases 0.000 description 1
- 208000002381 Brain Hypoxia Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 206010014522 Embolism venous Diseases 0.000 description 1
- 206010015719 Exsanguination Diseases 0.000 description 1
- 239000004812 Fluorinated ethylene propylene Substances 0.000 description 1
- 208000010496 Heart Arrest Diseases 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010029350 Neurotoxicity Diseases 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 206010044221 Toxic encephalopathy Diseases 0.000 description 1
- 208000030886 Traumatic Brain injury Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 238000011360 adjunctive therapy Methods 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 229910045601 alloy Inorganic materials 0.000 description 1
- 239000000956 alloy Substances 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 210000000013 bile duct Anatomy 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 238000009954 braiding Methods 0.000 description 1
- 208000029028 brain injury Diseases 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 210000004004 carotid artery internal Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 230000003727 cerebral blood flow Effects 0.000 description 1
- 210000004720 cerebrum Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 238000007428 craniotomy Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 208000031513 cyst Diseases 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 238000013156 embolectomy Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 231100000318 excitotoxic Toxicity 0.000 description 1
- 230000003492 excitotoxic effect Effects 0.000 description 1
- 238000002594 fluoroscopy Methods 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 230000002262 irrigation Effects 0.000 description 1
- 238000003973 irrigation Methods 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 201000002818 limb ischemia Diseases 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000037323 metabolic rate Effects 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 238000012806 monitoring device Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000000926 neurological effect Effects 0.000 description 1
- 230000004112 neuroprotection Effects 0.000 description 1
- 230000007135 neurotoxicity Effects 0.000 description 1
- 231100000228 neurotoxicity Toxicity 0.000 description 1
- 229910001000 nickel titanium Inorganic materials 0.000 description 1
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 210000003101 oviduct Anatomy 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 229920009441 perflouroethylene propylene Polymers 0.000 description 1
- 230000002572 peristaltic effect Effects 0.000 description 1
- 239000002831 pharmacologic agent Substances 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000004224 protection Effects 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 229960002668 sodium chloride Drugs 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 229940126585 therapeutic drug Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000002537 thrombolytic effect Effects 0.000 description 1
- 230000001732 thrombotic effect Effects 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 230000009529 traumatic brain injury Effects 0.000 description 1
- 210000000626 ureter Anatomy 0.000 description 1
- 238000007794 visualization technique Methods 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
- 210000004885 white matter Anatomy 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/32—Surgical cutting instruments
- A61B17/3205—Excision instruments
- A61B17/3207—Atherectomy devices working by cutting or abrading; Similar devices specially adapted for non-vascular obstructions
- A61B17/320758—Atherectomy devices working by cutting or abrading; Similar devices specially adapted for non-vascular obstructions with a rotating cutting instrument, e.g. motor driven
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B18/1492—Probes or electrodes therefor having a flexible, catheter-like structure, e.g. for heart ablation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M25/104—Balloon catheters used for angioplasty
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B2017/22001—Angioplasty, e.g. PCTA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B2017/22051—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for with an inflatable part, e.g. balloon, for positioning, blocking, or immobilisation
- A61B2017/22065—Functions of balloons
- A61B2017/22067—Blocking; Occlusion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B2017/22072—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for with an instrument channel, e.g. for replacing one instrument by the other
- A61B2017/22078—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for with an instrument channel, e.g. for replacing one instrument by the other for rotating the instrument within a channel, e.g. an optical fibre
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B2017/22079—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for with suction of debris
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/32—Surgical cutting instruments
- A61B17/3205—Excision instruments
- A61B17/3207—Atherectomy devices working by cutting or abrading; Similar devices specially adapted for non-vascular obstructions
- A61B17/320758—Atherectomy devices working by cutting or abrading; Similar devices specially adapted for non-vascular obstructions with a rotating cutting instrument, e.g. motor driven
- A61B2017/320775—Morcellators, impeller or propeller like means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00184—Moving parts
- A61B2018/00202—Moving parts rotating
- A61B2018/00208—Moving parts rotating actively driven, e.g. by a motor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2217/00—General characteristics of surgical instruments
- A61B2217/002—Auxiliary appliance
- A61B2217/005—Auxiliary appliance with suction drainage system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2218/00—Details of surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2218/001—Details of surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body having means for irrigation and/or aspiration of substances to and/or from the surgical site
- A61B2218/007—Aspiration
Definitions
- the field of the present application pertains to medical devices. More specifically, the present application is related to devices and methods for removal of thromboembolic obstructing matter from the human endovascular system, including cerebral arteries and other parts of the human body.
- Arterial and venous thromboembolic disease remains a major cause of death and disability despite the discovery of heparin by McLean and Howell in 1916 and its subsequent introduction into clinical practice in 1936.
- acute limb ischemia affects 14 persons per 100,000 in the United States population, with procedures relating to the treatment of acute arterial ischemia comprising 10% to 14% of the annual vascular surgical workload.
- Venous thromboembolism occurs at a fivefold greater frequency with recent estimates of 77.6 cases per 100,000 person-years.
- Strokes may be caused by a rupture or bleeding of a cerebral artery (“hemorrhagic stroke”), or a blockage in a cerebral artery due to a thromboembolism (“ischemic stroke”), Intracerebral hemorrhage (ICH) bleeding accounts for approximately 10-12% of all stroke cases in the United States.
- ICH Intracerebral hemorrhage
- Treatment choices for ICH are limited, and the effectiveness of currently available therapies is inadequate.
- Thrombolytics alone are not recommended, but are currently being investigated for use in conjunction with aspiration and other surgical techniques.
- Acute Ischemic Stroke is caused by blood clots blocking a blood vessel in the brain arteries.
- AIS is the third leading cause of death in the United States.
- the risk of having a stroke more than doubles each decade after the age of 55 According to the World Health Organization, more than 12 million people suffer Acute Ischemic Stroke worldwide each year. Of these, more than 4 million die and another 4 million are permanently disabled.
- Devices and methods disclosed in the prior art include several devices and methods such as: embolectomy devices, clot pullers, retrieving devices or separating devices with aspiration. While most of these devices are capable of removing blood clots from the human arteries, there is still a clinical need for a simple, quick and easy access with devices to the treatment site through tortuous brain arteries, and safe removal of blood clots in a single pass, Often, catheters used to remove clots from brain arteries get clogged after partial removal of clots even under absolute vacuum.
- the devices and methods of the present invention relate to removal of thromboembolic material that include but are not limited to: clots, thrombus, atheroma, fluid, polyps, cysts or other obstructive matter from endovascular system.
- the endovascular system includes arteries, veins, previously implanted stents, grafts, shunts, fistulas and the like. Removal of thromboembolic materials may also include locations outside of the endovascular system such as: body organs, head, ureters, bile ducts, fallopian tubes, localized tumors, cancerous tissue removal or other particular target site.
- a thromboembolic system which includes an extraction device and a drive unit.
- the thromboembolic system can be provided as a single unit with affixed components, or the components of the thromboembolic system may be detachable and attachable before, during or after the thromboembolic material removal procedure.
- a method for removing thromboembolic material from a patient using an thromboembolic system having an extraction device and drive unit comprising the steps of identifying the location of a thromboembolic material to be removed, providing an extraction device having an aspiration catheter and a rotational member, positioning the aspiration catheter at the treatment area proximally to the thromboembolic material, inserting the rotational member into the aspiration catheter, the rotational member having an elongate element having a distal tip such that the distal tip of the is adjacent to the distal end of the aspiration catheter, and activating aspiration and rotations of the rotational member to draw thromboembolic material into and through the lumen of the aspiration catheter, and outside the patient.
- the distal tip of the rotational member rotates along its longitudinal axis and is configured to dissolve thromboembolic material and facilitate its removal outside the patient.
- the rotational member rotates in angular motion distally at 100 to 500,000 RPM, and during rotation, creates centripetal forces at the end of the rotational member.
- the aspiration catheter is either affixed or detachable from the extraction device, and has a continuous inner diameter, and a tapered inner diameter.
- the aspiration catheter can also have a smaller inner diameter on the distal end with a larger diameter on the proximal end, or a larger diameter on the distal end and a smaller diameter on the proximal end, or combinations thereof.
- the extraction device may be experience reciprocal back and forth movement during the removal of thromboembolic material.
- the extraction device may be introduced to the treatment area with an attached aspiration catheter, or the aspiration catheter can be disconnected from the extraction device and introduced first to the treatment area using a support device that can include a guidewire, a dilator, a guiding catheter, an introducer, or combinations thereof.
- the aspiration catheter may include a single lumen catheter, or a multi lumen catheter, with an additional guidewire lumen provided for rapid exchange, or combinations thereof.
- the aspiration catheter may not be a part of the extraction device, and might include a neurocatheter, a peripheral catheter, a guiding catheter, and an introducer cannula, and have a flexible structure, a partially rigid structure, a fully rigid structure, or any combination thereof along its length.
- the extraction device may include a rigid distal portion suitable for removal of thromboembolic material from the patient's body and head, and where the rigid portion is made of metal, polymer or a combination of both.
- removal of the thromboembolic material may occur from locations within endovascular system, outside of the endovascular system, and combinations of both.
- the aspiration source such is a vacuum pump which is fluidly coupled with the extraction device and the aspiration catheter, and the aspiration can be applied in one of the following modes of operation: continuous mode, ON/OFF mode, modulated mode or combinations thereof.
- the extraction device has a side aperture in fluid communication with the aspiration catheter, and vacuum pump to regulate the level of vacuum used for aspiration.
- the aspiration catheter is positioned at the treatment area through an artery, a vein, a surgical aperture or a surgical incision using a femoral approach, a brachial approach, a radial approach, neck incision, a trans-carotid approach, and antegrade to the blood flow or retrograde to the blood flow approaches, as well as an invasive surgical approach including but not limited to a craniotomy and a burr hole.
- the aspiration catheter is deflectable through actuation on the proximal end thereof.
- the rotational member has a shaped distal tip having a larger diameter than the adjacent proximal portion, and is angularly rotated along its longitudinal axis in a continuous mode, ON/OFF mode, modulated mode or combinations thereof.
- the rotational member has one of the following profiles along its length: continuous, tapered in distal direction, tapered in proximal direction, multi tapered and combinations thereof.
- the rotational member is made of metal, metal alloy, polymer or combinations thereof, and comprises one longitudinal element selected from the group consisting of a single solid rod, multiple roads, bundle, tubing, wire strands/cable, coil, braid or combinations thereof,
- Rotational members and shafts are mechanical power-transmission devices used to transmit rotary motion through bends and curves. They can be placed inside catheters or sheaths and navigated around complex anatomy which would be otherwise impossible for a solid shaft.
- Flexible rotational members are made of layers of high-tensile wire wound over each other at opposing pitch angles. When torque is applied to the flexible shaft, the wire layers expand or contract depending on the direction of the rotation. If the torque causes the outer layer to contract, the layer underneath will expand. This creates a dynamic interference between the layers of the cable shaft resulting in high torsional stiffness—several times greater than the sum of the individual layers acting alone.
- Flexible rotational members also eliminate alignment problems because they do not require tight tolerances, and in general are 85 to 95% efficient because of low frictional losses.
- Flexible shafts can run from 0.020 to 1.25 inches in diameter and from 2 inches to 100 feet long. Very-high yield strength is critical in maintaining precise positioning response over many rotations. Yield strength can be as high as 400 lb/inch of torque at speeds reaching more than 18,000 rpm for some applications. Torque will determine the shaft diameter and its construction. A larger diameter typically equates to higher torque capacity.
- a flexible shaft is made of layers of wires. The number of layers, the number of wires per layer, and the size of the wires within each layer are all variables in flexible-shaft construction.
- Directional operation is whether the shaft will be transmitting torque in both directions (bidirectional) or only in one direction (unidirectional).
- a bidirectional shaft will typically have a construction consisting of many layers of smaller wires. This allows a rotational member to behave similarly in both directions—though it will always be a little stronger in one direction than in the other. If the shaft is required to transmit torque in only one direction, then it will have fewer layers of larger wires, which will make it very strong for the direction of operation and much weaker in the other direction.
- the point of helix is the torque load at which the flexible shaft begins to take the shape of a corkscrew or helix. It is always important to operate below this torque level, otherwise stresses within the wires increase and radial forces press the shaft outward against the casing, accelerating friction and wear. All flexible shafts either become longer or shorter when a torque is applied. The degree of change is typically small, but over long shaft lengths, it can become important to account for the axial stretch.
- the rotational member has one of the following configurations: circular, oval, square, rectangular, or combination thereof.
- the distal tip of the rotational member has one of the following shapes: arrowed, winged, finned, partial sinusoidal, blade, hook, loop, bend, coils, cable, braid or combinations thereof.
- the portion of the rotational member that is proximal to the distal tip has the one of the following shapes: arrowed, winged, finned, sinusoidal, partial sinusoidal, blade, hook, loop, bend, coil or combinations thereof.
- the rotational member has a distal tip, and the portion immediately proximal to the distal tip has one of the following configurations: continuous configuration, tapered configuration, reversed tapered configuration or 1 C combinations thereof.
- the position of the distal end of the aspiration catheter is adjusted relative to the position of the distal tip of the rotational member inside the aspiration catheter so that the relative distance between both ends is within 0 to 10 mm.
- the position of the distal end of the aspiration catheter is adjusted relative to the position of the distal tip of the rotational member outside the aspiration catheter so that the relative distance between both ends is within 0 to 10 mm.
- positioning of the distal tip of the rotational member with respect to the distal end of the aspiration catheter is done using visualization tools, intraoperative imaging, and measurement/localization indicators on one or both devices, such as radiopaque markers.
- the present invention may also include monitoring the placement of the aspiration catheter and the rotational member using a monitoring device, such as but not limited to, an image guided navigation system, a computed tomography scan, ultrasound and endoscopes, optiscopes; CT (Computed Tomography), MRI (Magnetic Resonance Imaging), radiographic technologies or Optical Coherence Tomography (OCT), neuro guided-navigational system.
- a monitoring device such as but not limited to, an image guided navigation system, a computed tomography scan, ultrasound and endoscopes, optiscopes; CT (Computed Tomography), MRI (Magnetic Resonance Imaging), radiographic technologies or Optical Coherence Tomography (OCT), neuro guided-navigational system.
- the gap formed between the rotational member's so radial diameter and the inner diameter of the aspiration catheter is between 0 to 5 mm.
- the distal tip of the rotational member can be housed inside the aspiration catheter, outside the aspiration catheter, even with the aspiration catheter, or adjustable between the inside and outside of the aspiration catheter, during the removal of thromboembolic material.
- the distal tip of the rotational member located inside the aspiration catheter is positioned thereto so as to remain in contemporaneous position with the distal end of the aspiration catheter.
- the rotational member traverses concomitant bends as the aspiration catheter during introduction to the treatment area, after introduction to the treatment area, during removal of thromboembolic material, and combinations thereof.
- the rotational member moves experiences angular motion distally in an off-centered manner with respect to the aspiration catheter.
- the rotational member may rotate clockwise, counter-clock wise or both.
- the rotational member is made of a single rotating member, multimember rotating members or both, in order to aid in breaking up the clot, and preventing the device from clogging during aspiration.
- an extraction device for removing thromboembolic material from a patient comprises an elongated rotational member having a tapered distal portion, an aspiration catheter at least partially surrounding the rotational member and having an aspiration passage, and a fitting assembly positioned on the distal end of the aspiration catheter to adjust the distal end of the aspiration catheter relative to the distal tip of the rotational member.
- the positioning of the rotational member and the aspiration catheter is configured to change the compliance of the thromboembolic material and to facilitate aspiration thereof outside the patient.
- a fitting assembly is positioned on the extraction device and attached to the aspiration catheter to adjust the distal end of the aspiration catheter relative to the distal tip of the rotational member.
- the positional adjustment of the distal end of the aspiration catheter relative to the distal tip of the rotational member using a fitting assembly can be done any time before, after or during removing the thromboembolic material.
- removing thromboembolic material from a patient is done using centripetal forces, the method comprising positioning an extraction device having an aspiration catheter and rotational member at the location of the thromboembolic material, adjusting the aspiration catheter such that the distal tip of the rotational member is adjacent the distal end of the aspiration catheter and within the distal-most end of the aspiration catheter, activating a vacuum within the aspiration catheter and activating rotations of the rotational member to remove blood clots outside the patient.
- the distal portion of the rotational member rotates along its longitudinal axis at a speed between 10 to 500,000 RPM, and is configured to break blood clots and to facilitate their aspiration outside the patient.
- Acute Ischemic Stroke is treated using an extraction catheter having an aspiration catheter and a rotational member by a method comprising the steps of identifying the location of thromboembolic material within cerebral vasculature of a patient, introducing an aspiration catheter through an incision to the treatment area, positioning the aspiration catheter proximally to the thromboembolic material, inserting a rotational member into the aspiration catheter, the rotational member comprising an elongate element having a distal tip such that the distal tip of the rotational member is adjacent to the distal end of the aspiration catheter, activating aspiration and rotations of the rotational member to draw thromboembolic material into and through the lumen of the aspiration catheter, and outside the patient.
- the distal tip of the rotational member applies centripetal forces to facilitate the removal of thromboembolic material outside the patient.
- irrigation is provided at least partially around the rotational member and within the aspiration lumen to further facilitate the removal of thromboembolic material.
- additional aspiration is provided proximally to the treatment area via an additional catheter or guiding catheter to further prevent small emboli dislodgment during the removal of blood clots and other tissue.
- the aspiration catheter and the rotational member are configured to deliver radiofrequency energy for blood vessel or tissue cauterization when necessary.
- additional bleeding may occur.
- Such bleeding is often caused by bleeding of non-effected vessels from the original bleed or from re-bleeding from the affected vessels. This new bleeding may cause another hemorrhagic stroke.
- a cauterizing approach may be used, including but not limited to electro cautery, ultrasound cautery and chemical cautery. Electro-cauterization is preferable to other forms of cauterization because it will not leach into neighboring tissue and cauterize outside of the intended boundaries.
- an occlusion balloon is deployed and expanded within the blood vessel to occlude the vessel around the treatment area to secure a more effective aspiration of the thromboembolic material outside the patient.
- the thromboembolic system includes an extraction device and a drive unit including an aspiration pump and an electrical motor.
- the whole system can be disposable, single-use or part of the system may be reusable, such as the drive unit.
- the method of removing thromboembolic material may involve delivering pharmacologic agent to the treatment location.
- agents may include, but are not limited to: tissue plasminogen activator, blood clot reducing agents, antiplatelet agents, and other GIIb/IIIa inhibitors.
- Some thrombectomy techniques employ aspiration alone to mechanically entrap and extract clots. Other techniques use aspiration in conjunction with clot retrievers or macerators to dislodge clots from the treatment location and aspirate outside the body. Aspiration techniques operate either using vacuum pumps or conventional syringes. While syringes are efficient in the aspiration of small amounts of fresh clots, suction pumps are often used to remove larger and well-organized clots. Suction pumps operate in the following modes including: static suction (a continuous pressure suction), modulated suction (vacuum increase/decrease suction), pulse suction (ON/OFF suction) or a combination thereof.
- Exposing clots to aspiration pressure pulsation or modulation will induce feebleness, fatigues, fracture and micro-cracks within the clot structure, thereby changing the compliance of the clots and enabling or facilitating removal of the clots outside the patient.
- hypothermia protects the brain are clearly multifactorial and include at least the following: reduction in brain metabolic rate, effects on cerebral blood flow, reduction of the critical threshold for oxygen delivery, blockade of excitotoxic mechanisms, calcium antagonism, preservation of protein synthesis, reduction of brain thermopooling, a decrease in edema formation, modulation of the inflammatory response, neuroprotection of the white matter and modulation of apoptotic cell death.
- Induced hypothermia may modulate neurotoxicity and, consequently, may play a unique role as an adjunctive therapy for treating brain injury after AIS and improving its devastating effects.
- the lowering of body temperature between 32-34° C. may be accomplished by many means including the use of cooling blankets, cooling helmets, endovascular cooling catheters, ice packs and ice water lavage.
- Use of hypothermia in conjunction with embodiments of the present invention may have a broad therapeutic use in the future.
- rotational member and “rotating member” of the device for removal of obstructive material from the patient refer to the same component.
- thromboembolic material removal system and “thromboembolic system” refer to same component.
- Aspiration also refer to the same action.
- Aspiration pump and “vacuum pump” and “suction pump” refer to the same component.
- Continuous aspiration and “static aspiration” also refer to the same action.
- FIG. 1 is a perspective view of a thrombotic material removal system according to the present invention.
- FIGS. 2A-2B is cross-sectional view of the extraction device as shown in FIG. 1 with the aspiration catheter detached from the extraction device.
- FIG. 2C is a cross-sectional view of a conventional Y-connector located on the aspiration catheter.
- FIG. 2D is a cross-sectional view of a conventional Y-connector located on the aspiration catheter with the rotational member fully secured inside the aspiration catheter.
- FIGS. 3A-3H show alternative tip configurations for the rotational member.
- FIGS. 4A-4D show alternative configurations the rotational member.
- FIGS. 5A-5D show alternative configurations of the rotational member.
- FIG. 6A shows the distal end of the rotational member positioned even with the distal end of the aspiration catheter.
- FIG. 6B shows the distal end of the rotational member positioned inside the aspiration catheter.
- FIG. 6C shows the distal end of the rotational member positioned outside of the aspiration catheter.
- FIG. 6D shows a gap between the rotating distal end on the rotational member and the inside diameter of the aspiration catheter.
- FIG. 7A is a cross-sectional view illustrating a placement of the aspiration catheter at the location of a clot within the human cerebral artery.
- FIG. 7B is a cross sectional view illustrating the rotational member of the clot removal device positioned inside the aspiration catheter of FIG. 7A .
- FIG. 7C is an enlarged view of the distal end of the aspiration catheter and the distal end of the rotational member of FIGS. 7A and 7B at the location of the clot undergoing aspiration.
- FIGS. 8A-8B illustrate an ON/OFF aperture within the extraction device for vacuum pulsation.
- FIGS. 9A-9B illustrate a longitudinal incision aperture in the extraction device for vacuum modulation.
- FIG. 10 illustrates the distal end of the extraction catheter at the location of the clot when aspiration pulsation or modulation is applied.
- FIG. 11 illustrates the extraction device with a dual aspiration to prevent emboli from migrating distally or into side branches.
- rotational member As used herein, “rotational member”, “cable”, “cable shaft”, “rotating member” all refer to the mechanical power-transmission devices used to transmit rotary motion through a straight treatment access, as well as through bends and curves
- FIG. 1 illustrates an exemplary embodiment of a thromboembolic removal system 100 .
- the thromboembolic removal system 100 includes two major components: the extraction device 101 and the drive unit 102 .
- the drive unit 102 includes at least one vacuum pump 103 to aspirate thromboembolic material, and an electrical motor 104 ,
- the main components of the extraction device 101 include an aspiration catheter 105 having a distal end 106 and a proximal end 107 , a rotational member 108 which is longitudinally extended through the extraction device 101 .
- the rotational member 108 has a distal end/tip 109 and a proximal end 110 that is located inside a connector 111 .
- the proximal end 110 of the rotational member 108 is attached via the connector 111 to the motor 104 located inside the drive unit 102 .
- the extraction device 101 also includes a fitting assembly 113 having a seal 114 , and a three-way Y-connector 115 having an aspiration outlet 116 and a fluid communication aperture 117 to regulate aspiration applied to the aspiration catheter 105 ,
- the aperture 117 is opened and closed based on procedural vacuum requirement using the operator's finger.
- the aspiration outlet 116 located on the extraction device 101 transports thromboembolic material through a tube 118 (which is coupled to the outlet 116 ) into an inlet 119 of the drive unit 102 .
- Thromboembolic material is further transported through the drive unit 102 , the outlet 120 in the drive unit 102 , and a tube 121 into a disposal bag 122 .
- the connector 111 located at the proximal end of the extraction device 101 supports connection of the proximal end 110 of rotational member 108 to the motor 104 located inside the drive unit 102 .
- connection methods that can be used to connect the distal end 110 of the rotational member 108 , and for that matter, the extraction device 101 , to the motor 104 located inside the drive unit 102 , including but not limited to conventional screws, snaps, and female/male interfaces.
- Such connection of the extraction device 101 to the drive unit 102 is convenient for packaging and handling since both parts are provided separately and attached by the operator before the use.
- the extraction device 101 and the drive unit 102 can be permanently fixed or connected together and provided as one disposable unit.
- the drive unit 102 may either contain (or be attachable to) a power source.
- the drive unit 102 may be attached to an electrical cable (not shown) that can be plugged into a wall outlet.
- the drive unit 102 may include one or more disposable or rechargeable batteries 123 to power the pump 103 and the motor 104 .
- the electrical motor 104 is shown and described in FIG. 1 , other devices that translate, oscillate, reciprocate, vibrate and/or the like may be substituted for the motion of the rotational member 108 , Thus, the operation of the thromboembolic material removal system 100 is not limited to rotational movement alone.
- various components described herein may be provided as part of the thromboembolic system 100 for removing thromboembolic material, including but not limited to an introducer, a guide catheter, a dilator, an occlusion balloon catheter, a trocar, as well as other tools appropriate for the procedure.
- an entire extraction device is fluidly coupled between the distal end 106 of the aspiration catheter 105 and the aspiration outlet 116 ,
- the aperture 117 serves to regulate the level of vacuum that is applied to the distal end 106 of the aspiration catheter 105 .
- the thromboembolic removal system 100 advantageously provides the ability to remove thromboembolic material from an endovascular and outside of the endovascular system within a patient while overcoming the drawbacks and limitations of the prior art.
- FIGS. 2A-2B is a cross-sectional view of the extraction device 101 as shown in FIG. 1 with the aspiration catheter 105 detached from the extraction device 101 .
- a radiopaque marker 200 is located on the distal portion 201 of the rotational member 108 . Such a radiopaque marker is not necessary if the distal tip 109 of the rotational member 108 is made of radiopaque material.
- the marker 112 at the distal end of the aspiration catheter 105 and the marker 200 located at the distal end of the rotational member 108 function to position the extraction device 101 at the treatment site, and to align the distal end 106 of the aspiration catheter 105 with respect to the distal tip 109 of the rotational member 108 .
- the proximal end 107 of the aspiration catheter 105 in FIG. 2B may be connected and disconnected from the fitting assembly 113 of the extraction device 101 .
- the aspiration catheter 105 may be permanently attached to the extraction device 101 when treatment sites are located in locations that are easier to access. If treatment locations are in areas that are tortuous and difficult to access, for example in patient cerebrovascular circulation, the aspiration catheter 105 can be disconnected from the extraction device 101 and introduced to the treatment area first. Also, the aspiration catheter 105 may be provided separately from the extraction device 101 .
- the aspiration catheter 105 may be a catheter such as a neurocatheter, a peripheral catheter, or a guiding catheter, as shown in the FIGS., or the aspiration catheter 105 may be embodied in the form of an introducer or cannula, or other similar device.
- the aspiration catheter 105 having the inner distal lumen 206 may have a fixed diameter, distally tapered diameter or combination of all (not shown).
- the aspiration catheter 105 may have a flexible structure along its length, such as a rigid structure, a partially rigid structure, or combination of both, at along its entire length, or along different sections thereof.
- the distal end 106 of the aspiration catheter 105 can also be provided to be a deflectable distal end 106 by using an actuation feature positioned on the proximal end 107 of the aspiration catheter 105 (not shown) and attached to the fitting assembly 113 if necessary.
- Such actuation features are known in the art.
- the fitting assembly 113 consists of a tube 202 made of metal or polymer, and a Touhy-Borst valve/adapter 204 .
- the rigid tube 202 is permanently attached to the distal portion 203 of the Y-connector 115 and it partially surrounds the rotational member 108 .
- the Touhy-Borst valve 114 is positioned on the tube 202 .
- Measurement marks may be incorporated on the tube 202 (not shown) to allow longitudinal and precise adjustment/movement of the Touhy-Borst valve 204 with the attached aspiration catheter 105 along the tube 202 .
- Touhy-Borst valves are well known in the medical device field and often are used to seal other devices, mostly guidewires and catheters, that are introduced inside the body to prevent back flow of blood. Examples of such devices include but are not limited to Touhy-Borst valve model 80330 from Qosina, Edgewood, N.Y.
- the Touhy-Borst valve 204 is positioned around the tube 202 such way that it can be repositioned along the tube 202 as desired.
- the proximal end 106 of the aspiration catheter 105 is attached to the Touhy-Borst valve 204 so it can move back and forth along the tube 202 as well.
- Repositioning the Touhy-Borst valve 204 with an attached aspiration catheter 105 along the tube 202 will move the flexible catheter 105 longitudinally along the rotational member 108 . This movement allows the distal end 106 of the aspiration catheter 105 to be accurately positioned relative to the distal tip 109 of the rotational member 108 as needed.
- the Touhy-Borst valve 114 is tightened around the tube 202 , which squeezes the seal 114 inside the Touhy-Borst valve 204 and around the tube 202 at a fixed position/location along the tube 202 .
- a conventional Y-connector 207 having a distal end 208 is attached to the aspiration catheter 105 .
- the proximal portion 209 of the Y-connector 207 has a valve 210 .
- the distal portion of the rotational member 108 is introduced (partially or fully) through the proximal valve 210 of the Y-connector 207 and inside the aspiration catheter 105 .
- the tube 211 may be made of polymer or metal, There is a stopper 212 affixed to the tube 211 .
- the stopper 212 can be made of polymer or metal and serves to position the tube 211 at a specific location inside the Y-connector 207 . When the stopper 212 reaches the proximal end 209 of the Y-connector 207 , it cannot be moved inside the valve 210 . A very proximal portion 110 of the rotational member 108 and the connector 111 together function to connect the rotational member 108 to the power drive/motor (not shown).
- the rotational member 108 is fully positioned inside the aspiration catheter 105 .
- the stopper 212 is at the proximal end 209 of the Y-connector 207 , and the distal end of the rotational member 108 is positioned at the distal end 106 of the aspiration catheter 105 .
- the tube 211 is positioned inside the Y-connector 207 .
- the stopper 212 is aligned such way that it prevents extensive exposure of the distal tip 209 of the rotational member 108 outside the distal end 106 of the aspiration catheter 106 .
- an angiographic adjustment can be made to assure that the marker 200 located on the distal tip 109 of the rotational member 108 is aligned with the marker 112 located on the distal end 106 of the aspiration catheter 105 .
- Positioning of the distal end 106 of the aspiration catheter 105 using the alignment of the Touhy-Borst valve 204 along the tube 202 can be performed anytime during or before the thromboembolic material removal procedure.
- the tube 202 should be long enough so that a desirable distance can be maintained between the distal tip 109 of the rotational member 108 and the distal end 106 of the aspiration catheter 105 when the distal tip 109 of the rotational member 108 is inside the aspiration catheter 105 or outside the aspiration catheter 105 .
- the Touhy-Borst valve 204 is always located on the tube 202 to guarantee a seal when it is tightened after positioning, and during aspiration and thromboembolic material removal.
- the tube 202 is fluidly connected with the aspiration catheter 105 and the aspiration outlet 116 of the extraction device 101 .
- FIG. 1 A block diagram illustrating an exemplary computing environment in accordance with the present disclosure.
- FIG. 1 A block diagram illustrating an exemplary computing environment in accordance with the present disclosure.
- FIG. 1 A block diagram illustrating an exemplary computing environment in accordance with the present disclosure.
- FIG. 1 A block diagram illustrating an exemplary computing environment in accordance with the present disclosure.
- FIG. 1 A block diagram illustrating an exemplary computing environment in accordance with the present disclosure.
- an extension tube may be attached to the proximal end 205 of the Y-connector 115 and a longer rotational member 108 can be extended through the extension tube.
- Such extended rotational member 108 will be attached to the motor 104 the same manner as described above.
- the rotational member 108 that is connected to the motor 104 is configured to move in angular motion longitudinally.
- the rotational mode may include but it is not limited to: continuous rotations, ON/OFF rotations, modulated rotations, or combinations thereof,
- a rotational speed may be anywhere within 100-200,000 RPM.
- the rotational member 108 may be made at least partially from metal, metal alloys, polymer or combinations of the above (e.g., composites), and may have a cross-sectional contour that is shaped as circular, oval, square, rectangular, or combinations thereof.
- the rotational member 108 may be a single solid rod or wire, a multiple solid rod or wires, tubing, cable, strands, coil, braid or combinations thereof along its length.
- the rotational member 108 of the extraction device 101 may also be attached in an off-centered manner with respect to the motor 104 to provide an off-center angular motion of the rotational member 108 .
- centripetal forces are based on three factors: (i) the velocity of the object as it follows the circular path; (ii) the object's distance from the center of the rotating path; and (iii) the mass of the object.
- Radiofrequency energy maybe delivered to the distal portion 201 of the rotational member 108 including the distal end/tip 109 of the rotational member 108 and to the treatment area. If the aspiration catheter 105 of the extraction device 101 has a metallic portion included distally (not shown), it also can serve to deliver radiofrequency energy to the treatment area.
- FIGS. 3A-3F illustrate several alternative embodiments of the distal tip 109 of the rotational member 108 .
- FIG. 3A shows an arrow-shaped distal tip 300 .
- FIG. 3B shows a fin-like distal tip 301 with an enlarged extending from one side.
- FIG. 3C shows a winged distal tip 302 that resembles a hammer-head.
- FIG. 3D shows a curved distal tip 303
- FIG. 3E shows a blade-like distal tip 304 where the tip 109 is enlarged along a short length.
- FIG. 3A shows an arrow-shaped distal tip 300 .
- FIG. 3B shows a fin-like distal tip 301 with an enlarged extending from one side.
- FIG. 3C shows a winged distal tip 302 that resembles a hammer-head.
- FIG. 3D shows a curved distal tip 303
- FIG. 3E shows a blade-like distal tip 304
- 3F shows a looped distal tip 305 that resembles a hook
- Other shapes are also possible for the distal tip 109 , such as a partial (quarter or half) sinusoidal or full sinusoidal shape, baskets, and a variety of bends. All of these embodiments may be formed as part of (i.e., in one piece with) the distal tip 109 of the rotational member 108 as shown in FIGS. 3A-3F .
- the distal tip 109 can be provided as additional components that are attached to the distal tip 109 using known techniques such as bonding, welding, soldering, crimping, fusing or any other suitable and similar techniques.
- Such components for the distal tip 109 may be made of metal, polymer, rubber, ceramic, or combinations thereof. Any configuration of the distal tip 109 of the rotational member 108 that can effectively disintegrate thromboembolic material within the entry into the aspiration catheter 105 , or effectively facilitates removal of thromboembolic material within the aspiration catheter 105 can be used for this application. As shown in FIGS. 3A-3F , the distal tip 109 may have shapes that are larger than the adjacent proximal portion of the rotational member 108 . As shown in FIGS. 3A-3F , the overall dimension of the primary configuration at the distal tip 300 , 301 , 302 , 303 , 304 and 305 is larger than dimension of most adjacent proximal portion of the rotational member 108 .
- FIG. 3G shows a distal tip 306 that is attached to the distal end of the rotational member 108 and is considered the distal tip 109 of the rotational member 108 .
- a tip 306 can be made of any of the materials described above, and attached to the rotational member 108 using any suitable technique known in the art, including but not limited to bonding, welding, crimping, and soldering.
- the distal tip 306 shown in FIG. 3G has a straight configuration with a rounded tip.
- FIG. 3H shows another embodiment of a distal tip 307 that can be attached to the rotational member 108 .
- the distal tip 307 is configured with a bend that is bent at an angle of a.
- FIGS. 4A-4B show alternative configurations for the distal portion 201 of the rotational member 108 , and are referred to herein as the primary and secondary configurations.
- the primary configurations are located on the distal tip 109 of the rotational member 108 while the secondary configurations are located proximally to the primary configurations along the rotational member 108 .
- These embodiments are illustrative and include but are not limited to any of the single or multiple shape configurations described above, either formed or attached at the distal tip 109 of the transmission member 108 , formed or attached proximally to the distal tip 109 of the rotational member 108 , or any combination thereof.
- FIG. 4A shows an arrow-shaped distal tip 300 for the distal tip 109 , and additional blade-shaped expanded section 400 located proximally to the arrow-shaped distal tip 300 .
- the distance between the arrow-shaped distal tip 300 and the section 400 can range from 0 mm to 200 mm, and is preferably within 5 mm-50 mm.
- FIG. 4B shows another embodiment that includes a fin-like distal tip 301 and an additional blade-shaped expanded section 400 located proximally to the fin-like distal tip 301 .
- the dimensions of the primary configuration at the tip 300 and 301 and secondary configurations 400 and 401 are larger than dimension of the most adjacent proximal portion of the rotational member 108 .
- All configurations of the distal portion of the rotational member 108 shown in FIGS. 3A-3F and FIGS. 4A-4B have a continuous dimensional size. Such dimensional size may continue along the entire length of the rotational member 108 , or have a tapered or stepped transition into a larger or smaller size proximally.
- a more compliant structure can be used for the rotational member 108 , such as a cable or other multi-wired constructions
- a cable is a flexible element whose sub-elements are stranded together such that all of the strands share the load: either rotational torque, bending stress, longitudinal tensile or both, Cables can comprise two or more wires running side by side, bonded, twisted, or braided together that form a single assembly. One end of the cable can be connected to a rotational device and the other left free for rotation.
- a great advantage of using cable for that rotational member 108 is that cable may undergo complex bends and are literally compliant, which allows them to be forgiving of misalignment. Also, when a cable passes around complex anatomy, bending stress in any single strand is far lower than in a rod or wire of the same diameter if exposed to the same bends. While cable for the transmission of rotational motions is used primary in low speed applications, use of polymer coatings or jackets would further reduce rotational friction and may be applicable for a higher speed. The most important feature of the cable-driven rotational motion is that a cable can bend in three dimensions. Such characteristics make cables very unique motion transmitters for endovascular and any other medical applications. Often, polymer strand(s) are used within cable structures such as KevlarTM as an elastic backup.
- FIGS. 4C-4D illustrate alternative configurations of the rotational member 108 including cables and multi wires.
- FIG. 4C shows a cable 402 attached to a rod, wire or tube 404 via attachment member 403 .
- Such cables are usually made of metal or metals alloys, including but not limited to SST, Nitinol, Titanium, Silver, Copper, InconelTM and others, with the addition of KevlarTM, VectranTM and coated with PTFE, FEP, Nylon and other polymers.
- the cable 402 is connected to the rod, wire or tube 404 via the connecting element 403 by bonding crimping, welding, soldering and other known methods.
- the cable 402 can also be directly attached to the rod, wire or tube 404 without an attaching element 403 using similar attachment methods.
- the cable 402 may be a single element serving as an entire rotational member 108 .
- the cap 405 can be formed using any of the configurations shown in FIGS. 3A-3H and FIGS. 4A-4B , and 5 A- 50 (described below).
- FIG. 4D shows a straight wire bundle 406 having two wires that are connected to a rod, wire or tube 408 via a connector 407 .
- a bundle 406 may include two or more straight wires, either connected to each other, partially connected to each other, or totally independent (i.e., not connected to each other).
- the wire bundle 406 can be covered with a polymer sheath to provide a low-friction cover when needed.
- a cap 409 may be attached to the distal end of the wire bundle 406 .
- the advantage of using a straight wire bundle on the distal end of the rotational member 108 is that a bending stress in any single wire is far lower than in a wire of the same diameter if exposed to the same bends. While the embodiment of FIG.
- Caps 405 and 409 may not always be required, and in such a case, a natural structure of the cable ( FIG. 4C ) and two wires ( FIG. 2D ) could serve as the distal tip of the rotational member.
- FIGS. 5A-5D illustrate alternative embodiments of the distal portion 201 of the rotational member 108 .
- FIG. 5A shows an arrow-shaped tip 300 positioned on the distal tip 109 of the rotational member 108 and having a tapered segment 500 proximally adjacent to the tip 300 .
- Such a tapered portion 500 of the rotational member 108 can continue along the rotational member 108 , or have a tapered or stepped transition into a larger or smaller size proximally.
- FIG. 5B shows a winged distal tip 302 positioned on the distal tip 109 of the rotational member 108 and having a tapered segment 501 proximally adjacent to the tip 302 .
- the tapered portion 501 of the rotational member 108 may transition into a continuous portion 502 .
- the tapered portion 501 can also continue along the rotational member 108 or have a tapered or stepped transition into a larger or smaller size proximally.
- FIG. 5C shows a winged distal tip 302 located on the distal tip 109 of the rotational member 108 .
- the distal-most portion 503 of the rotational member 108 has a reverse taper.
- the immediate proximal portion 504 of the rotational member 108 has a conventional taper (smaller to larger) configuration.
- the tapered immediate proximal portion 504 of the rotational member 108 may transition into a continuous portion 505 .
- FIG. 5D shows a blade-like distal tip 304 located on the distal tip 109 of the rotational member 108 .
- the distal-most portion 506 of the rotational member 108 has a tapered configuration.
- the secondary shape provides a blade-shaped expanded section 400 that is located on the tapered portion 506 .
- the proximal segment 507 to the secondary blade 400 has a reverse taper that transitions into a conventional taper 508 .
- the tapered portion 508 of the rotational member 108 may transition into a continuous portion 509 , or continue as a taper along the rotational member 108 , or have a tapered or stepped transition into a larger or smaller size proximally.
- the combinations and numbers of the primary and secondary configurations that can be implemented on the distal portion 201 of the rotational member 108 may vary. In one embodiment, there might be no primary shape at all, and one or more secondary shapes; in another embodiment, there might be one primary shape and no secondary shape; in yet another embodiment, there might one primary shape and one or more secondary shapes; and so on.
- FIG. 6A shows the distal tip 109 of the rotational member 109 in a flush position with the distal end 106 of the aspiration catheter 105 .
- FIG. 6B shows the distal end 106 of the aspiration catheter 105 and the distal portion 201 of the rotational member 108 .
- the distance 600 between the distal tip 109 of the rotational member 108 and the distal end 106 of the aspiration catheter 105 when the distal tip 109 is inside the aspiration catheter 105 can range between 0.0 mm and 50 mm, most preferably between 0.0 mm and 5 mm as measured using the fitting assembly 113 or any suitable visualization, intraoperative imaging, or other means.
- FIG. 6C shows the distal end 106 of the aspiration catheter 105 and the distal portion 201 of the rotational member 108 .
- the distance 601 between the distal tip 109 of the rotational member 108 and the distal end 106 of the aspiration catheter 105 when the distal tip 109 is inside the aspiration catheter 105 can range between 0.0 mm and 50 mm, most preferably between 0.0 mm and 5 mm as measured using any suitable visualization or intraoperative imaging, To simplify the positioning process, and to provide better visibility using any suitable visualization means, the distal portion 201 of the rotational member 108 and the distal end 106 of the aspiration catheter 105 can be made of radiopaque material.
- a radiopaque marker 112 can be positioned on the distal end 106 of the aspiration catheter 105 and another radiopaque marker 200 can be positioned on the distal end 201 of the rotational member 108 .
- the aspiration catheter 105 will have to navigate a tortuous anatomy either within the endovascular system or outside the endovascular system, and the ability to position the distal tip 109 of the rotational member 108 correctly inside the distal end 106 of the aspiration catheter 105 may have a crucial impact on device safety and efficacy.
- FIG. 6D shows the distal end 106 of the aspiration catheter 105 and the distal tip 109 of the rotational member 108 .
- the distal tip 109 of the rotational member 108 is positioned inside the distal end 106 of the aspiration catheter 105 . It is important that the radial gap 602 between the distal tip 109 of the rotating rotational member 108 and the wall of the inner lumen 206 at the distal end 106 of the aspiration catheter 105 is sufficient to not induce damages to the inner surface of the aspiration catheter 105 .
- the gap 602 should be anywhere between 0.0 mm to 10 mm larger than the diameter of the internal lumen 206 , with a preferred gap between 0.0 mm to 2 mm.
- Adjustment of the distances 600 and 601 plays a very important role in the safe and efficient removal of thromboembolic material.
- the distal tip 109 of the rotational member 108 may be positioned outside the distal end 106 of the aspiration catheter 105 to macerate or disintegrate clots or other material before the material reaches the distal end 106 of the aspiration catheter 105 , which is under vacuum during the thromboembolic material removal.
- this increases the system efficacy.
- the distal tip 109 of the rotational member 108 may be repositioned accordingly using the fitting assembly 113 and the distance marks on the tube 202 as described hereinabove in FIGS. 1 and 2 .
- the Touhy-Borst valve 204 may be positioned accordingly along the tube 202 to guarantee that the distal tip 109 of the rotational member 108 is inside the aspiration catheter 105 .
- Such positioning of the Touhy-Borst valve 204 using distance marks on the tube 202 may be performed in addition to observing the alignment of the radiopaque marker 112 at the distal end 106 of the aspiration catheter 105 with the distal tip 109 using fluoroscopy or any other appropriate visualization method.
- the fitting assembly 113 provides adjustment for the distal tip 109 with respect to the distal end 106 of the aspiration catheter 105 , so the distal tip 109 located inside the aspiration catheter 105 can be positioned therein so as to remain in contemporaneous position with the distal end 106 of the aspiration catheter 105 if necessary.
- the aspiration catheter 105 can be made of a polymer material and/or reinforced with a metal or polymer coiling, braiding and combinations of both, as well as including an internal lumen with a TeflonTM liner.
- FIG. 7A shows an example of a patient suffering from Ischemic Stroke having blood clots located in the Middle Cerebral Artery (MCA) 700 .
- MCA Middle Cerebral Artery
- the MCA is one of the three major paired arteries that supply blood to the cerebrum and arises from the internal carotid artery.
- Blood clots located in the M1 segment are the most common situations for patients treated with medical devices.
- Such blood clots located in the cerebrovascular circulation is identified in the hospital by symptoms, CT scan, MRI or fluoroscopic evaluation.
- the aspiration catheter 105 is introduced to the cerebral vessel 700 and the treatment site 701 in such a way that the distal end 106 of the aspiration catheter 105 is in the vicinity of the blood clots to be removed.
- Introduction of the aspiration catheter 105 to the treatment site 701 can be done using a support element.
- Use of support elements is well known in the medical device field and includes, but is not limited to, use of guidewires, dilators, additional catheters, guiding catheters or combinations thereof.
- the aspiration catheter 105 is introduced to the treatment site 701 operating in an over-the-wire approach using a conventional guidewire 702 .
- the aspiration catheter 105 can also have a rapid exchange guidewire feature, and may be introduced to the treatment area in a rapid exchange fashion, After positioning the distal end 106 of the aspiration catheter 105 at the location of the blood clots, the guidewire 702 is removed. In the case where a rapid exchange guidewire is used, the guidewire may remain inside the body.
- the aspiration catheter 105 can be positioned in the body using one of the following approaches: through femoral approach, brachial approach, surgical approach from any feasible location including patient neck, radial approach, antegrade to the blood flow, or retrograde to the blood flow approach.
- the aspiration catheter 105 may be disconnected from the extraction device as shown in FIG. 2 or it may be any other suitable catheter that can access the treatment site 701 .
- the next step is to introduce the rotational member 108 of the extraction device 101 inside the aspiration catheter 105 such that the distal tip 109 of the rotational member 108 is adjacent the distal end 106 of the aspiration catheter 105 , and within the catheter's distal-most end.
- the rotational member 108 is positioned at the treatment location 701 , activation of aspiration and rotation of the rotational member 108 will follow to initiate the removal of blood clots outside the patient.
- the rotational member 108 rotates along its longitudinal axis at a speed between 100 to 200,000 RPM, and is configured to break blood clots and facilitate the aspiration of blood clots outside the patient.
- the distal end 106 of the aspiration catheter 105 can be repositioned relative to the distal tip 109 of the rotational member 108 at any time before or during the removal of blood clots. It is desirable that the distal tip 109 of the rotational member 108 remain in a contemporaneous position with the distal end 106 of the aspiration catheter 105 . Also, the distal end of the extraction device 101 may be repositioned back and forth accordingly to ensure that blood clots are removed effectively.
- the guidewire 702 can also remain in place at the treatment location at a position that will not interfere with the rotational member 108 , In such circumstances, a physician/operator would have quick access to the guidewire 702 when and if needed.
- FIG. 7C shows a close-up view of the distal end 106 of the aspiration catheter 105 and the distal tip 109 of the rotational member 108 in the cerebral artery 700 at blood clot location 701 under aspiration, which is shown by the arrow 703 .
- Thromboembolic material may be aspirated into the aspiration catheter 105 using a variety of aspiration modes, including but not limited to continuous aspiration, ON/OFF aspiration, modulated aspiration (Higher/Lower), or combinations thereof
- FIG. 7C also shows an optional occlusion balloon 704 that provides at least a partial vessel seal around the area of thromboembolic material removal so as to minimize the aspiration of blood from neighboring vessels.
- the occlusion balloon 704 may be positioned proximal to the treatment area 701 as shown in FIG. 7C , or it can be positioned distal to the treatment area (not shown), or occlusion balloons can be position distal and proximal to the treatment location 701 (not shown), To ensure a better positioning of the extraction device 101 at the treatment location 701 , the aspiration catheter 105 may have a smaller distal dimension than its proximal dimension.
- the removal of thromboembolic material may also include infusing the vessel or treatment site with fluid (e.g., sodium chloride, thrombolytic agent or therapeutic drug) to assist in the disintegration of, or to break up, the clot or tissue into a particle size that can then be more easily and quickly aspirated through a lumen of the aspiration catheter 105 .
- fluid e.g., sodium chloride, thrombolytic agent or therapeutic drug
- Thrombolytic agents may include, but are not limited to: tissue plasminogen activator, blood clot reducing agents, antiplatelet agents, and other GIIb/IIIa inhibitors.
- the rotational member 108 traverses concomitant bends as the aspiration catheter 105 during their introduction to the treatment area and during the removal of thromboembolic material.
- FIG. 8A is a close-up view of the aperture 117 located on the 3 way Y-connector 115 , which is shown as having a circular opening 800 .
- FIG. 8B shows the opening 800 closed using the operator's finger 801 .
- Vacuum pressure pulsation can be achieved using any aperture within the extraction device 101 which normally is a well-sealed passageway structure between the distal end 106 of the aspiration catheter 105 (inlet) and the outlet 120 of the vacuum pump 103 as shown in FIG. 1 , The operator can manually open and close the opening 800 using a finger. Opening and covering the opening 800 (ON/OFF) will produce pulsing vacuum pressure at the distal end 106 of the aspiration catheter 105 .
- the aperture 117 may have a regular opening configuration, including but not limited to, circular 800 (as shown), oval, square, rectangular, octagonal, hexagonal, or any non-regular configuration that can be conveniently covered by a finger.
- the ON or open time duration of the aperture 117 may be anywhere between 0.01 to 10 seconds.
- the OFF or closed time of the aperture 117 may also be in the same range of 0.01 to 10 seconds. Any combination of ON and OFF time is suitable for clot removal according to the present invention,
- FIG. 9A is a close-up view of the aperture 117 having a longitudinal incision opening 900 .
- Vacuum pressure modulation at the distal end 106 of the aspiration catheter 105 can be achieved in a similar way as the pulsation described above in connection with FIGS. 8A-8B .
- Different openings may be used for the aperture 117 , including but not limited to: longitudinal incision 900 (as shown), slit or notch.
- Such incision opening 900 will allow the operator to move the finger 901 along the opening 900 so as to increase or decrease the size of the opening 900 as shown in FIG.
- Increasing and decreasing finger coverage over the incision 900 will produce pressure modulation at the distal end 106 of the aspiration catheter 105 , and change compliance of the clots.
- the speed of the movement of the finger 901 along the opening 900 depends on the desired aspiration modulation characteristics and may result in full opening and closure of the opening 900 , partial opening and closure of opening 900 , and can also either be combined with ON/OFF pulsing.
- FIG. 10 is a close-up view of the distal end 106 of the aspiration catheter 105 positioned at the clot location 1000 , Arrows 1001 illustrate pulsation or modulation stress applied by the vacuum displayed by arrow 1002 from within the catheter 105 . Closing and opening the aperture 117 by the operator will cause ON/OFF stress on the clots 1000 , weakening their structure by inducing fractures causing internal/external clot separation 1003 , This illustrates the changing of the compliance of the clots 1000 , thereby accelerating removal of the clots through the aspiration catheter 105 outside the patient.
- Providing a saline flush during blood clot removal may greatly improve clot clearing by flushing clots to the blood container. Delivery of liquid during clot removal may be by achieved by flushing the extraction device 101 , providing continuous flush distally to the clot removal area, or a combination of both.
- an additional aspiration source 1100 may be positioned over or around the aspiration catheter 105 at a location within the distance x from the distal end 106 , shown in FIG. 11 .
- This distance x can be 1-10 cm from the distal end 106 to further prevent dislodgement of small emboli 1102 from clot 1101 , or distal movement or flooding into other vascular branches 1103 as shown in FIG. 11 .
- Such additional aspiration source 1100 can be a conventional guiding catheter 1104 or another catheter or sheath routinely used for such procedure.
- An external aspiration source (not shown) can be attached to the proximal outlet 1105 of the aspiration catheter 105 , and the proximal outlet of the guiding catheter 1104 . This dual-aspiration approach will assure that any emboli created during removal of blood clots will be further aspirated through the secondary aspiration source 1100 .
- Some embodiments of the present invention include cooling of brain tissue before, during or after the removal of thromboembolic material.
- cooling brain tissue may involve local endovascular cooling, cooling the patient's neck, cooling the patient's head and/or cooling the patient's body.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medical Informatics (AREA)
- Vascular Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Plasma & Fusion (AREA)
- Physics & Mathematics (AREA)
- Cardiology (AREA)
- Otolaryngology (AREA)
- Child & Adolescent Psychology (AREA)
- Biophysics (AREA)
- Pulmonology (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Surgical Instruments (AREA)
Abstract
Description
- This application claims priority to U.S. Provisional Application No. 62/124,406, filed on Dec. 16, 2014, and is a continuation-in-part of co-pending application Ser. No. 14/668,622, filed Mar. 25, 2015, whose entire disclosure is incorporated herewith as though fully set forth herein.
- The field of the present application pertains to medical devices. More specifically, the present application is related to devices and methods for removal of thromboembolic obstructing matter from the human endovascular system, including cerebral arteries and other parts of the human body.
- Arterial and venous thromboembolic disease remains a major cause of death and disability despite the discovery of heparin by McLean and Howell in 1916 and its subsequent introduction into clinical practice in 1936. Each year, acute limb ischemia affects 14 persons per 100,000 in the United States population, with procedures relating to the treatment of acute arterial ischemia comprising 10% to 14% of the annual vascular surgical workload. Venous thromboembolism occurs at a fivefold greater frequency with recent estimates of 77.6 cases per 100,000 person-years.
- Strokes may be caused by a rupture or bleeding of a cerebral artery (“hemorrhagic stroke”), or a blockage in a cerebral artery due to a thromboembolism (“ischemic stroke”), Intracerebral hemorrhage (ICH) bleeding accounts for approximately 10-12% of all stroke cases in the United States. ICH has long been associated with high rates of morbidity and mortality. Treatment choices for ICH are limited, and the effectiveness of currently available therapies is inadequate. Thrombolytics alone are not recommended, but are currently being investigated for use in conjunction with aspiration and other surgical techniques.
- While intracranial hemorrhage is caused by blood clots located outside the blood vessels in the brain, Acute Ischemic Stroke (AIS) is caused by blood clots blocking a blood vessel in the brain arteries. AIS is the third leading cause of death in the United States, Each year, approximately 700,000 people suffer an Acute Ischemic Stroke, and more than 100,000 people die each year in the United States. Nearly three-quarters of all these strokes occur in people over the age of 65. The risk of having a stroke more than doubles each decade after the age of 55, According to the World Health Organization, more than 12 million people suffer Acute Ischemic Stroke worldwide each year. Of these, more than 4 million die and another 4 million are permanently disabled.
- Endovascular and outside of endovascular thromboembolic disease remain very widespread causes of death and disability with no ideally effective treatment currently available. Thus, there is a significant need for improved devices, methods and systems for treating thromboembolic disease.
- There are many approaches for removing thromboembolic material from the body, either surgical or using catheter devices for endovascular and outside endovascular removal of obstructive matter, such as blood clots, thrombus, atheroma, plaque and the like. These techniques are related to rotating baskets or impellers, cutters, high pressure fluid injections, Archimedes screw, vacuum, rotating wires and other means as described in U.S. Pat. Nos. 4,732,154; 4,737,153; 4,771,774; 4,886,490; 4,883,458; 4,923,462; 4,966,604; 5,041,082; 5,047,040; 5,135,531; 5,180,376; 5,226,909; 5,334,211; 5,376,100; 5,443,443; 5,462,529; 5,485,042; 5,501,694; 5,556,408; 5,569,275; 5,630,806; 5,653,696; 5,695,507; 5,766,191; 5,795,322; 5,843,031; 5,873,882; 5,876.414; 5,911,734; 5,947,940; 5,972,019; 7,037,316; 7,179,269; 7,235,088; 7,666,161; 7,763,010; 7,842,006; 7,842,055; 7,938,820; 7,942,852; 8,062,317; 8,414,543; 8,414,543; 8,535,290 and 8,545,447; and US Applications Nos., 2014/0324080 and 2014/0330286.
- Removal of thromboembolic material and blood clots from brain arteries are described in the following U.S. Pat. Nos. 7,063,707; 7,316,692; 7,931,659; 833,796; 8,366,735; 8,460,312; 8,366,735; 8,784,441; 8,801,748, 8,814,892, as well as Simon S. et al., “Exploring the efficacy of cyclic vs. static aspiration in cerebral thrombectomy model: an initial proof of concept study”, Journal of Neurointerventional Surgery 2014 November; 6(9): 677-83; among others. Devices and methods disclosed in the prior art include several devices and methods such as: embolectomy devices, clot pullers, retrieving devices or separating devices with aspiration. While most of these devices are capable of removing blood clots from the human arteries, there is still a clinical need for a simple, quick and easy access with devices to the treatment site through tortuous brain arteries, and safe removal of blood clots in a single pass, Often, catheters used to remove clots from brain arteries get clogged after partial removal of clots even under absolute vacuum. In such situations, physicians typically use a “corking” approach to grab the clot with a vacuum and then remove the clogged catheter outside the body to remove the clot, Next they clean the clots from the catheter and navigate the catheter back up to the targeted occlusion to remove the remaining clot. Risks related with device manipulations and multiple accessing of the treatment site, as well as the extended time required for removing blood clots from arteries, may lead to another stroke and have a crucial impact on short and long term clinical outcomes. Thus, there is a need for more efficient and effective devices that facilitate a quick and single pass for the removal of thromboembolic material.
- The devices and methods of the present invention relate to removal of thromboembolic material that include but are not limited to: clots, thrombus, atheroma, fluid, polyps, cysts or other obstructive matter from endovascular system. The endovascular system includes arteries, veins, previously implanted stents, grafts, shunts, fistulas and the like. Removal of thromboembolic materials may also include locations outside of the endovascular system such as: body organs, head, ureters, bile ducts, fallopian tubes, localized tumors, cancerous tissue removal or other particular target site.
- In one embodiment the present invention, a thromboembolic system is provided which includes an extraction device and a drive unit. The thromboembolic system can be provided as a single unit with affixed components, or the components of the thromboembolic system may be detachable and attachable before, during or after the thromboembolic material removal procedure.
- In another embodiment of the present invention, a method for removing thromboembolic material from a patient using an thromboembolic system having an extraction device and drive unit is provided, the method comprising the steps of identifying the location of a thromboembolic material to be removed, providing an extraction device having an aspiration catheter and a rotational member, positioning the aspiration catheter at the treatment area proximally to the thromboembolic material, inserting the rotational member into the aspiration catheter, the rotational member having an elongate element having a distal tip such that the distal tip of the is adjacent to the distal end of the aspiration catheter, and activating aspiration and rotations of the rotational member to draw thromboembolic material into and through the lumen of the aspiration catheter, and outside the patient. The distal tip of the rotational member rotates along its longitudinal axis and is configured to dissolve thromboembolic material and facilitate its removal outside the patient.
- In another embodiment, the rotational member rotates in angular motion distally at 100 to 500,000 RPM, and during rotation, creates centripetal forces at the end of the rotational member.
- In another embodiment, the aspiration catheter is either affixed or detachable from the extraction device, and has a continuous inner diameter, and a tapered inner diameter. The aspiration catheter can also have a smaller inner diameter on the distal end with a larger diameter on the proximal end, or a larger diameter on the distal end and a smaller diameter on the proximal end, or combinations thereof.
- In some embodiments, the extraction device may be experience reciprocal back and forth movement during the removal of thromboembolic material.
- In some other embodiments, the extraction device may be introduced to the treatment area with an attached aspiration catheter, or the aspiration catheter can be disconnected from the extraction device and introduced first to the treatment area using a support device that can include a guidewire, a dilator, a guiding catheter, an introducer, or combinations thereof.
- In yet another embodiment, the aspiration catheter may include a single lumen catheter, or a multi lumen catheter, with an additional guidewire lumen provided for rapid exchange, or combinations thereof.
- In another embodiment, the aspiration catheter may not be a part of the extraction device, and might include a neurocatheter, a peripheral catheter, a guiding catheter, and an introducer cannula, and have a flexible structure, a partially rigid structure, a fully rigid structure, or any combination thereof along its length.
- In some other embodiments, the extraction device may include a rigid distal portion suitable for removal of thromboembolic material from the patient's body and head, and where the rigid portion is made of metal, polymer or a combination of both.
- In yet another embodiment, removal of the thromboembolic material may occur from locations within endovascular system, outside of the endovascular system, and combinations of both.
- In another embodiment, the aspiration source such is a vacuum pump which is fluidly coupled with the extraction device and the aspiration catheter, and the aspiration can be applied in one of the following modes of operation: continuous mode, ON/OFF mode, modulated mode or combinations thereof.
- In yet another embodiment, the extraction device has a side aperture in fluid communication with the aspiration catheter, and vacuum pump to regulate the level of vacuum used for aspiration.
- In some embodiments, the aspiration catheter is positioned at the treatment area through an artery, a vein, a surgical aperture or a surgical incision using a femoral approach, a brachial approach, a radial approach, neck incision, a trans-carotid approach, and antegrade to the blood flow or retrograde to the blood flow approaches, as well as an invasive surgical approach including but not limited to a craniotomy and a burr hole.
- In some embodiments, the aspiration catheter is deflectable through actuation on the proximal end thereof.
- In another embodiment, the rotational member has a shaped distal tip having a larger diameter than the adjacent proximal portion, and is angularly rotated along its longitudinal axis in a continuous mode, ON/OFF mode, modulated mode or combinations thereof.
- In another embodiment, the rotational member has one of the following profiles along its length: continuous, tapered in distal direction, tapered in proximal direction, multi tapered and combinations thereof.
- In another embodiment, the rotational member is made of metal, metal alloy, polymer or combinations thereof, and comprises one longitudinal element selected from the group consisting of a single solid rod, multiple roads, bundle, tubing, wire strands/cable, coil, braid or combinations thereof, Rotational members and shafts are mechanical power-transmission devices used to transmit rotary motion through bends and curves. They can be placed inside catheters or sheaths and navigated around complex anatomy which would be otherwise impossible for a solid shaft. Flexible rotational members are made of layers of high-tensile wire wound over each other at opposing pitch angles. When torque is applied to the flexible shaft, the wire layers expand or contract depending on the direction of the rotation. If the torque causes the outer layer to contract, the layer underneath will expand. This creates a dynamic interference between the layers of the cable shaft resulting in high torsional stiffness—several times greater than the sum of the individual layers acting alone.
- Flexible rotational members also eliminate alignment problems because they do not require tight tolerances, and in general are 85 to 95% efficient because of low frictional losses. Flexible shafts can run from 0.020 to 1.25 inches in diameter and from 2 inches to 100 feet long. Very-high yield strength is critical in maintaining precise positioning response over many rotations. Yield strength can be as high as 400 lb/inch of torque at speeds reaching more than 18,000 rpm for some applications. Torque will determine the shaft diameter and its construction. A larger diameter typically equates to higher torque capacity. A flexible shaft is made of layers of wires. The number of layers, the number of wires per layer, and the size of the wires within each layer are all variables in flexible-shaft construction. For a given diameter, this construction can be varied to achieve different performance characteristics, including torque, bending flexibility, torsional deflection, axial stretch, bidirectional capability, and other parameters, Directional operation is whether the shaft will be transmitting torque in both directions (bidirectional) or only in one direction (unidirectional). A bidirectional shaft will typically have a construction consisting of many layers of smaller wires. This allows a rotational member to behave similarly in both directions—though it will always be a little stronger in one direction than in the other. If the shaft is required to transmit torque in only one direction, then it will have fewer layers of larger wires, which will make it very strong for the direction of operation and much weaker in the other direction.
- The point of helix is the torque load at which the flexible shaft begins to take the shape of a corkscrew or helix. It is always important to operate below this torque level, otherwise stresses within the wires increase and radial forces press the shaft outward against the casing, accelerating friction and wear. All flexible shafts either become longer or shorter when a torque is applied. The degree of change is typically small, but over long shaft lengths, it can become important to account for the axial stretch.
- In yet another embodiment, the rotational member has one of the following configurations: circular, oval, square, rectangular, or combination thereof.
- In some embodiments, the distal tip of the rotational member has one of the following shapes: arrowed, winged, finned, partial sinusoidal, blade, hook, loop, bend, coils, cable, braid or combinations thereof.
- In some embodiments, the portion of the rotational member that is proximal to the distal tip has the one of the following shapes: arrowed, winged, finned, sinusoidal, partial sinusoidal, blade, hook, loop, bend, coil or combinations thereof.
- In another embodiment, the rotational member has a distal tip, and the portion immediately proximal to the distal tip has one of the following configurations: continuous configuration, tapered configuration, reversed tapered configuration or 1C combinations thereof.
- In another embodiment, the position of the distal end of the aspiration catheter is adjusted relative to the position of the distal tip of the rotational member inside the aspiration catheter so that the relative distance between both ends is within 0 to 10 mm.
- In another embodiment, the position of the distal end of the aspiration catheter is adjusted relative to the position of the distal tip of the rotational member outside the aspiration catheter so that the relative distance between both ends is within 0 to 10 mm.
- In some embodiments, positioning of the distal tip of the rotational member with respect to the distal end of the aspiration catheter is done using visualization tools, intraoperative imaging, and measurement/localization indicators on one or both devices, such as radiopaque markers.
- The present invention may also include monitoring the placement of the aspiration catheter and the rotational member using a monitoring device, such as but not limited to, an image guided navigation system, a computed tomography scan, ultrasound and endoscopes, optiscopes; CT (Computed Tomography), MRI (Magnetic Resonance Imaging), radiographic technologies or Optical Coherence Tomography (OCT), neuro guided-navigational system.
- In another embodiment, the gap formed between the rotational member's so radial diameter and the inner diameter of the aspiration catheter is between 0 to 5 mm.
- In various embodiments, the distal tip of the rotational member can be housed inside the aspiration catheter, outside the aspiration catheter, even with the aspiration catheter, or adjustable between the inside and outside of the aspiration catheter, during the removal of thromboembolic material.
- In another embodiment, the distal tip of the rotational member located inside the aspiration catheter is positioned thereto so as to remain in contemporaneous position with the distal end of the aspiration catheter.
- In yet another embodiment, the rotational member traverses concomitant bends as the aspiration catheter during introduction to the treatment area, after introduction to the treatment area, during removal of thromboembolic material, and combinations thereof.
- In another embodiment, the rotational member moves experiences angular motion distally in an off-centered manner with respect to the aspiration catheter.
- In yet another embodiment, the rotational member may rotate clockwise, counter-clock wise or both.
- In another embodiment, the rotational member is made of a single rotating member, multimember rotating members or both, in order to aid in breaking up the clot, and preventing the device from clogging during aspiration.
- In another embodiment, an extraction device for removing thromboembolic material from a patient comprises an elongated rotational member having a tapered distal portion, an aspiration catheter at least partially surrounding the rotational member and having an aspiration passage, and a fitting assembly positioned on the distal end of the aspiration catheter to adjust the distal end of the aspiration catheter relative to the distal tip of the rotational member. The positioning of the rotational member and the aspiration catheter is configured to change the compliance of the thromboembolic material and to facilitate aspiration thereof outside the patient.
- In yet another embodiment of the present invention, a fitting assembly is positioned on the extraction device and attached to the aspiration catheter to adjust the distal end of the aspiration catheter relative to the distal tip of the rotational member. Such positioning of the distal tip of the rotational member and the aspiration catheter provides a wide range of options to safely and more effectively change the compliance of the thromboembolic material to improve the efficacy of the system to remove the thromboembolic material outside the patient.
- In yet another embodiment, the positional adjustment of the distal end of the aspiration catheter relative to the distal tip of the rotational member using a fitting assembly can be done any time before, after or during removing the thromboembolic material.
- In another embodiment, removing thromboembolic material from a patient is done using centripetal forces, the method comprising positioning an extraction device having an aspiration catheter and rotational member at the location of the thromboembolic material, adjusting the aspiration catheter such that the distal tip of the rotational member is adjacent the distal end of the aspiration catheter and within the distal-most end of the aspiration catheter, activating a vacuum within the aspiration catheter and activating rotations of the rotational member to remove blood clots outside the patient. The distal portion of the rotational member rotates along its longitudinal axis at a speed between 10 to 500,000 RPM, and is configured to break blood clots and to facilitate their aspiration outside the patient.
- In another embodiment, Acute Ischemic Stroke is treated using an extraction catheter having an aspiration catheter and a rotational member by a method comprising the steps of identifying the location of thromboembolic material within cerebral vasculature of a patient, introducing an aspiration catheter through an incision to the treatment area, positioning the aspiration catheter proximally to the thromboembolic material, inserting a rotational member into the aspiration catheter, the rotational member comprising an elongate element having a distal tip such that the distal tip of the rotational member is adjacent to the distal end of the aspiration catheter, activating aspiration and rotations of the rotational member to draw thromboembolic material into and through the lumen of the aspiration catheter, and outside the patient. During this method, the distal tip of the rotational member applies centripetal forces to facilitate the removal of thromboembolic material outside the patient.
- In another embodiment, irrigation is provided at least partially around the rotational member and within the aspiration lumen to further facilitate the removal of thromboembolic material.
- In yet another embodiment, additional aspiration is provided proximally to the treatment area via an additional catheter or guiding catheter to further prevent small emboli dislodgment during the removal of blood clots and other tissue.
- In another embodiment, the aspiration catheter and the rotational member are configured to deliver radiofrequency energy for blood vessel or tissue cauterization when necessary. Occasionally, during the removal of thromboembolic material from outside of the endovascular space such as ICH, additional bleeding may occur. Such bleeding is often caused by bleeding of non-effected vessels from the original bleed or from re-bleeding from the affected vessels. This new bleeding may cause another hemorrhagic stroke. To minimize additional blood-loss and prevent exsanguination, a cauterizing approach may be used, including but not limited to electro cautery, ultrasound cautery and chemical cautery. Electro-cauterization is preferable to other forms of cauterization because it will not leach into neighboring tissue and cauterize outside of the intended boundaries.
- In another embodiment, an occlusion balloon is deployed and expanded within the blood vessel to occlude the vessel around the treatment area to secure a more effective aspiration of the thromboembolic material outside the patient.
- In yet another embodiment of the present invention, the thromboembolic system includes an extraction device and a drive unit including an aspiration pump and an electrical motor. The whole system can be disposable, single-use or part of the system may be reusable, such as the drive unit.
- In some embodiments, the method of removing thromboembolic material may involve delivering pharmacologic agent to the treatment location. Such agents may include, but are not limited to: tissue plasminogen activator, blood clot reducing agents, antiplatelet agents, and other GIIb/IIIa inhibitors.
- Some thrombectomy techniques employ aspiration alone to mechanically entrap and extract clots. Other techniques use aspiration in conjunction with clot retrievers or macerators to dislodge clots from the treatment location and aspirate outside the body. Aspiration techniques operate either using vacuum pumps or conventional syringes. While syringes are efficient in the aspiration of small amounts of fresh clots, suction pumps are often used to remove larger and well-organized clots. Suction pumps operate in the following modes including: static suction (a continuous pressure suction), modulated suction (vacuum increase/decrease suction), pulse suction (ON/OFF suction) or a combination thereof. Use of a static suction is well known in the art and mostly relies on a high vacuum pressure; a higher vacuum pressure level produces higher efficacy. However, in some applications where clots are larger than the catheter or cannula diameter, and the clot is well organized, the catheter or cannula is often clogged and requires device removal and cleaning. Examples of such applications include but are not limited to Acute Ischemic Stroke or Intracranial Hemorrhage. Using aspiration pulsation or modulation may improve device efficacy either using aspiration alone or in conjunction with other mechanical enhancements. Exposing clots to aspiration pressure pulsation or modulation will induce feebleness, fatigues, fracture and micro-cracks within the clot structure, thereby changing the compliance of the clots and enabling or facilitating removal of the clots outside the patient.
- Many experimental studies in the last decade have confirmed that moderate hypothermia show protection against ischemic and non-ischemic brain hypoxia, traumatic brain injury, anoxic injury following resuscitation after cardiac arrest and other neurological insults including Acute Ischemic Stroke (AIS). Many adverse events that occur in the injured brain at a cellular and molecular level are highly temperature-sensitive and are thus a good target for induced hypothermia. The basic mechanisms through which hypothermia protects the brain are clearly multifactorial and include at least the following: reduction in brain metabolic rate, effects on cerebral blood flow, reduction of the critical threshold for oxygen delivery, blockade of excitotoxic mechanisms, calcium antagonism, preservation of protein synthesis, reduction of brain thermopooling, a decrease in edema formation, modulation of the inflammatory response, neuroprotection of the white matter and modulation of apoptotic cell death. Induced hypothermia may modulate neurotoxicity and, consequently, may play a unique role as an adjunctive therapy for treating brain injury after AIS and improving its devastating effects. The lowering of body temperature between 32-34° C. may be accomplished by many means including the use of cooling blankets, cooling helmets, endovascular cooling catheters, ice packs and ice water lavage. Use of hypothermia in conjunction with embodiments of the present invention may have a broad therapeutic use in the future.
- As used herein: “rotational member” and “rotating member” of the device for removal of obstructive material from the patient refer to the same component. In addition, as used herein: “thromboembolic material removal system” and “thromboembolic system” refer to same component. “Aspiration”, “Vacuum” and “suction” also refer to the same action. “Aspiration pump”, “vacuum pump” and “suction pump” refer to the same component. “Continuous aspiration” and “static aspiration” also refer to the same action.
- Certain preferred embodiments and modifications thereof will become apparent to those skilled in the art from the detailed description below having reference to the figures that follow.
-
FIG. 1 is a perspective view of a thrombotic material removal system according to the present invention. -
FIGS. 2A-2B is cross-sectional view of the extraction device as shown inFIG. 1 with the aspiration catheter detached from the extraction device. -
FIG. 2C is a cross-sectional view of a conventional Y-connector located on the aspiration catheter. -
FIG. 2D is a cross-sectional view of a conventional Y-connector located on the aspiration catheter with the rotational member fully secured inside the aspiration catheter. -
FIGS. 3A-3H show alternative tip configurations for the rotational member. -
FIGS. 4A-4D show alternative configurations the rotational member. -
FIGS. 5A-5D show alternative configurations of the rotational member. -
FIG. 6A shows the distal end of the rotational member positioned even with the distal end of the aspiration catheter. -
FIG. 6B shows the distal end of the rotational member positioned inside the aspiration catheter. -
FIG. 6C shows the distal end of the rotational member positioned outside of the aspiration catheter. -
FIG. 6D shows a gap between the rotating distal end on the rotational member and the inside diameter of the aspiration catheter. -
FIG. 7A is a cross-sectional view illustrating a placement of the aspiration catheter at the location of a clot within the human cerebral artery. -
FIG. 7B is a cross sectional view illustrating the rotational member of the clot removal device positioned inside the aspiration catheter ofFIG. 7A . -
FIG. 7C is an enlarged view of the distal end of the aspiration catheter and the distal end of the rotational member ofFIGS. 7A and 7B at the location of the clot undergoing aspiration. -
FIGS. 8A-8B illustrate an ON/OFF aperture within the extraction device for vacuum pulsation. -
FIGS. 9A-9B illustrate a longitudinal incision aperture in the extraction device for vacuum modulation. -
FIG. 10 illustrates the distal end of the extraction catheter at the location of the clot when aspiration pulsation or modulation is applied. -
FIG. 11 illustrates the extraction device with a dual aspiration to prevent emboli from migrating distally or into side branches. - The following detailed description is of the best presently contemplated modes of carrying out the invention. This description is not to be taken in a limiting sense, but is made merely for the purpose of illustrating general principles of embodiments of the invention. The scope of the invention is best defined by the appended claims.
- As used herein, “rotational member”, “cable”, “cable shaft”, “rotating member” all refer to the mechanical power-transmission devices used to transmit rotary motion through a straight treatment access, as well as through bends and curves
-
FIG. 1 illustrates an exemplary embodiment of athromboembolic removal system 100. Thethromboembolic removal system 100 includes two major components: the extraction device 101 and the drive unit 102. The drive unit 102 includes at least one vacuum pump 103 to aspirate thromboembolic material, and an electrical motor 104, The main components of the extraction device 101 include anaspiration catheter 105 having adistal end 106 and aproximal end 107, a rotational member 108 which is longitudinally extended through the extraction device 101. The rotational member 108 has a distal end/tip 109 and a proximal end 110 that is located inside a connector 111. The proximal end 110 of the rotational member 108 is attached via the connector 111 to the motor 104 located inside the drive unit 102. There is a radiopaque marker 112 located on thedistal end 106 of theaspiration catheter 105. - The extraction device 101 also includes a fitting assembly 113 having a seal 114, and a three-way Y-connector 115 having an aspiration outlet 116 and a fluid communication aperture 117 to regulate aspiration applied to the
aspiration catheter 105, The aperture 117 is opened and closed based on procedural vacuum requirement using the operator's finger. The aspiration outlet 116 located on the extraction device 101 transports thromboembolic material through a tube 118 (which is coupled to the outlet 116) into an inlet 119 of the drive unit 102. Thromboembolic material is further transported through the drive unit 102, the outlet 120 in the drive unit 102, and a tube 121 into adisposal bag 122. - The connector 111 located at the proximal end of the extraction device 101 supports connection of the proximal end 110 of rotational member 108 to the motor 104 located inside the drive unit 102. There are many optional connection methods that can be used to connect the distal end 110 of the rotational member 108, and for that matter, the extraction device 101, to the motor 104 located inside the drive unit 102, including but not limited to conventional screws, snaps, and female/male interfaces. Such connection of the extraction device 101 to the drive unit 102 is convenient for packaging and handling since both parts are provided separately and attached by the operator before the use. Also, the extraction device 101 and the drive unit 102 can be permanently fixed or connected together and provided as one disposable unit. The drive unit 102 may either contain (or be attachable to) a power source. For example, in some embodiments, the drive unit 102 may be attached to an electrical cable (not shown) that can be plugged into a wall outlet. In other embodiments, the drive unit 102 may include one or more disposable or rechargeable batteries 123 to power the pump 103 and the motor 104.
- While the electrical motor 104 is shown and described in
FIG. 1 , other devices that translate, oscillate, reciprocate, vibrate and/or the like may be substituted for the motion of the rotational member 108, Thus, the operation of the thromboembolicmaterial removal system 100 is not limited to rotational movement alone. - In connection with the system of
FIG. 1 , various components described herein may be provided as part of thethromboembolic system 100 for removing thromboembolic material, including but not limited to an introducer, a guide catheter, a dilator, an occlusion balloon catheter, a trocar, as well as other tools appropriate for the procedure. - When the
aspiration catheter 105 is attached to the extraction device 101 as shown inFIG. 1 , an entire extraction device is fluidly coupled between thedistal end 106 of theaspiration catheter 105 and the aspiration outlet 116, The aperture 117 serves to regulate the level of vacuum that is applied to thedistal end 106 of theaspiration catheter 105. - As will be described in greater detail below, the
thromboembolic removal system 100 advantageously provides the ability to remove thromboembolic material from an endovascular and outside of the endovascular system within a patient while overcoming the drawbacks and limitations of the prior art. -
FIGS. 2A-2B is a cross-sectional view of the extraction device 101 as shown inFIG. 1 with theaspiration catheter 105 detached from the extraction device 101. As shown inFIG. 2A , aradiopaque marker 200 is located on thedistal portion 201 of the rotational member 108. Such a radiopaque marker is not necessary if thedistal tip 109 of the rotational member 108 is made of radiopaque material. The marker 112 at the distal end of theaspiration catheter 105 and themarker 200 located at the distal end of the rotational member 108 function to position the extraction device 101 at the treatment site, and to align thedistal end 106 of theaspiration catheter 105 with respect to thedistal tip 109 of the rotational member 108. - The
proximal end 107 of theaspiration catheter 105 inFIG. 2B may be connected and disconnected from the fitting assembly 113 of the extraction device 101. Theaspiration catheter 105 may be permanently attached to the extraction device 101 when treatment sites are located in locations that are easier to access. If treatment locations are in areas that are tortuous and difficult to access, for example in patient cerebrovascular circulation, theaspiration catheter 105 can be disconnected from the extraction device 101 and introduced to the treatment area first. Also, theaspiration catheter 105 may be provided separately from the extraction device 101. In such a case, theaspiration catheter 105 may be a catheter such as a neurocatheter, a peripheral catheter, or a guiding catheter, as shown in the FIGS., or theaspiration catheter 105 may be embodied in the form of an introducer or cannula, or other similar device. - The
aspiration catheter 105 having the inner distal lumen 206 may have a fixed diameter, distally tapered diameter or combination of all (not shown Theaspiration catheter 105 may have a flexible structure along its length, such as a rigid structure, a partially rigid structure, or combination of both, at along its entire length, or along different sections thereof. Also, when needed to navigate difficult anatomies, thedistal end 106 of theaspiration catheter 105 can also be provided to be a deflectabledistal end 106 by using an actuation feature positioned on theproximal end 107 of the aspiration catheter 105 (not shown) and attached to the fitting assembly 113 if necessary. Such actuation features are known in the art. - The fitting assembly 113 consists of a tube 202 made of metal or polymer, and a Touhy-Borst valve/
adapter 204. The rigid tube 202 is permanently attached to the distal portion 203 of the Y-connector 115 and it partially surrounds the rotational member 108. The Touhy-Borst valve 114 is positioned on the tube 202. - Measurement marks may be incorporated on the tube 202 (not shown) to allow longitudinal and precise adjustment/movement of the Touhy-
Borst valve 204 with the attachedaspiration catheter 105 along the tube 202. - Touhy-Borst valves are well known in the medical device field and often are used to seal other devices, mostly guidewires and catheters, that are introduced inside the body to prevent back flow of blood. Examples of such devices include but are not limited to Touhy-Borst valve model 80330 from Qosina, Edgewood, N.Y. The Touhy-
Borst valve 204 is positioned around the tube 202 such way that it can be repositioned along the tube 202 as desired. Theproximal end 106 of theaspiration catheter 105 is attached to the Touhy-Borst valve 204 so it can move back and forth along the tube 202 as well. Repositioning the Touhy-Borst valve 204 with an attachedaspiration catheter 105 along the tube 202 will move theflexible catheter 105 longitudinally along the rotational member 108. This movement allows thedistal end 106 of theaspiration catheter 105 to be accurately positioned relative to thedistal tip 109 of the rotational member 108 as needed. Once thedistal end 106 of theaspiration catheter 105 is at the desired position with respect to thedistal tip 109 of the rotational member 108, the Touhy-Borst valve 114 is tightened around the tube 202, which squeezes the seal 114 inside the Touhy-Borst valve 204 and around the tube 202 at a fixed position/location along the tube 202. - In
FIG. 2C , a conventional Y-connector 207 having adistal end 208 is attached to theaspiration catheter 105. The proximal portion 209 of the Y-connector 207 has a valve 210. The distal portion of the rotational member 108 is introduced (partially or fully) through the proximal valve 210 of the Y-connector 207 and inside theaspiration catheter 105. On the proximal portion of the rotational member 108 there is an additional tube 211 having a distal end 212 that is still outside the valve 210 of the Y-connector 207. The tube 211 may be made of polymer or metal, There is a stopper 212 affixed to the tube 211. The stopper 212 can be made of polymer or metal and serves to position the tube 211 at a specific location inside the Y-connector 207. When the stopper 212 reaches the proximal end 209 of the Y-connector 207, it cannot be moved inside the valve 210. A very proximal portion 110 of the rotational member 108 and the connector 111 together function to connect the rotational member 108 to the power drive/motor (not shown). - In
FIG. 2D , the rotational member 108 is fully positioned inside theaspiration catheter 105. The stopper 212 is at the proximal end 209 of the Y-connector 207, and the distal end of the rotational member 108 is positioned at thedistal end 106 of theaspiration catheter 105. The tube 211 is positioned inside the Y-connector 207. The stopper 212 is aligned such way that it prevents extensive exposure of the distal tip 209 of the rotational member 108 outside thedistal end 106 of theaspiration catheter 106. To further prevent the often undesirable exposure of thedistal tip 109 of therotational member 208 outside thedistal end 106 of theaspiration catheter 105, an angiographic adjustment can be made to assure that themarker 200 located on thedistal tip 109 of the rotational member 108 is aligned with the marker 112 located on thedistal end 106 of theaspiration catheter 105. - Positioning of the
distal end 106 of theaspiration catheter 105 using the alignment of the Touhy-Borst valve 204 along the tube 202 can be performed anytime during or before the thromboembolic material removal procedure. The tube 202 should be long enough so that a desirable distance can be maintained between thedistal tip 109 of the rotational member 108 and thedistal end 106 of theaspiration catheter 105 when thedistal tip 109 of the rotational member 108 is inside theaspiration catheter 105 or outside theaspiration catheter 105. The Touhy-Borst valve 204 is always located on the tube 202 to guarantee a seal when it is tightened after positioning, and during aspiration and thromboembolic material removal. The tube 202 is fluidly connected with theaspiration catheter 105 and the aspiration outlet 116 of the extraction device 101. - Other alternative embodiments to control the position of the
distal tip 109 of the rotational member 108 with respect to thedistal end 106 of theaspiration catheter 105 may include, but are not limited to: placing applicable spacers or inserts on the rotational member 108 inside the extraction catheter 101 between theproximal end 107 of theaspiration catheter 105 and the Y-connector 207 (not shown); providing the connector 111 with an adjustable length, so the overall length of the rotational member 108 may be adjusted (longer or shorter) with respect to thedistal end 106 of theaspiration catheter 105 as desired any time before or during thromboembolic material removal; and any other suitable methods and solutions. - If the drive unit 102 is a reusable unit and is located outside the sterilized field, an extension tube may be attached to the proximal end 205 of the Y-connector 115 and a longer rotational member 108 can be extended through the extension tube. Such extended rotational member 108 will be attached to the motor 104 the same manner as described above.
- The rotational member 108 that is connected to the motor 104 is configured to move in angular motion longitudinally. The rotational mode may include but it is not limited to: continuous rotations, ON/OFF rotations, modulated rotations, or combinations thereof, A rotational speed may be anywhere within 100-200,000 RPM. The rotational member 108 may be made at least partially from metal, metal alloys, polymer or combinations of the above (e.g., composites), and may have a cross-sectional contour that is shaped as circular, oval, square, rectangular, or combinations thereof. The rotational member 108 may be a single solid rod or wire, a multiple solid rod or wires, tubing, cable, strands, coil, braid or combinations thereof along its length.
- The rotational member 108 of the extraction device 101 may also be attached in an off-centered manner with respect to the motor 104 to provide an off-center angular motion of the rotational member 108.
- When the
distal tip 109 of the rotational member 108 rotates, it follows a circular path and is accelerating because the velocity is constantly changing directions. Accelerations are caused by forces acting on therotating tip 109 and are called the centripedal forces or “center seeking” forces which means that the force is always directed towards the center of the circle. The centripetal forces are based on three factors: (i) the velocity of the object as it follows the circular path; (ii) the object's distance from the center of the rotating path; and (iii) the mass of the object. When thromboembolic material is vacuumed into thedistal end 106 of theaspiration catheter 105 and thedistal tip 109 of the rotational member 108 rotates in a circular motion, therotating tip 109 will enable thromboembolic material separation, partition and will facilitate its aspiration proximally. - If necessary, electro-cauterization may be performed before, during or after thromboembolic material removal using the extraction device 101. Radiofrequency energy maybe delivered to the
distal portion 201 of the rotational member 108 including the distal end/tip 109 of the rotational member 108 and to the treatment area. If theaspiration catheter 105 of the extraction device 101 has a metallic portion included distally (not shown), it also can serve to deliver radiofrequency energy to the treatment area. -
FIGS. 3A-3F illustrate several alternative embodiments of thedistal tip 109 of the rotational member 108.FIG. 3A shows an arrow-shapeddistal tip 300.FIG. 3B shows a fin-likedistal tip 301 with an enlarged extending from one side.FIG. 3C shows a winged distal tip 302 that resembles a hammer-head.FIG. 3D shows a curveddistal tip 303,FIG. 3E shows a blade-likedistal tip 304 where thetip 109 is enlarged along a short length.FIG. 3F shows a looped distal tip 305 that resembles a hook, Other shapes are also possible for thedistal tip 109, such as a partial (quarter or half) sinusoidal or full sinusoidal shape, baskets, and a variety of bends. All of these embodiments may be formed as part of (i.e., in one piece with) thedistal tip 109 of the rotational member 108 as shown inFIGS. 3A-3F . Alternatively, as shown inFIGS. 3G and 3H , thedistal tip 109 can be provided as additional components that are attached to thedistal tip 109 using known techniques such as bonding, welding, soldering, crimping, fusing or any other suitable and similar techniques. Such components for thedistal tip 109 may be made of metal, polymer, rubber, ceramic, or combinations thereof. Any configuration of thedistal tip 109 of the rotational member 108 that can effectively disintegrate thromboembolic material within the entry into theaspiration catheter 105, or effectively facilitates removal of thromboembolic material within theaspiration catheter 105 can be used for this application. As shown inFIGS. 3A-3F , thedistal tip 109 may have shapes that are larger than the adjacent proximal portion of the rotational member 108. As shown inFIGS. 3A-3F , the overall dimension of the primary configuration at thedistal tip -
FIG. 3G shows adistal tip 306 that is attached to the distal end of the rotational member 108 and is considered thedistal tip 109 of the rotational member 108. Such atip 306 can be made of any of the materials described above, and attached to the rotational member 108 using any suitable technique known in the art, including but not limited to bonding, welding, crimping, and soldering. Thedistal tip 306 shown inFIG. 3G has a straight configuration with a rounded tip. -
FIG. 3H shows another embodiment of a distal tip 307 that can be attached to the rotational member 108. The distal tip 307 is configured with a bend that is bent at an angle of a. -
FIGS. 4A-4B show alternative configurations for thedistal portion 201 of the rotational member 108, and are referred to herein as the primary and secondary configurations. The primary configurations are located on thedistal tip 109 of the rotational member 108 while the secondary configurations are located proximally to the primary configurations along the rotational member 108. These embodiments are illustrative and include but are not limited to any of the single or multiple shape configurations described above, either formed or attached at thedistal tip 109 of the transmission member 108, formed or attached proximally to thedistal tip 109 of the rotational member 108, or any combination thereof. -
FIG. 4A shows an arrow-shapeddistal tip 300 for thedistal tip 109, and additional blade-shaped expanded section 400 located proximally to the arrow-shapeddistal tip 300. The distance between the arrow-shapeddistal tip 300 and the section 400 can range from 0 mm to 200 mm, and is preferably within 5 mm-50 mm. -
FIG. 4B shows another embodiment that includes a fin-likedistal tip 301 and an additional blade-shaped expanded section 400 located proximally to the fin-likedistal tip 301. As shown inFIGS. 4A-4B , the dimensions of the primary configuration at thetip FIGS. 3A-3F andFIGS. 4A-4B have a continuous dimensional size. Such dimensional size may continue along the entire length of the rotational member 108, or have a tapered or stepped transition into a larger or smaller size proximally. - For treatment areas with a difficult access, such as the cerebral or distal peripheral vasculature, a more compliant structure can be used for the rotational member 108, such as a cable or other multi-wired constructions, A cable is a flexible element whose sub-elements are stranded together such that all of the strands share the load: either rotational torque, bending stress, longitudinal tensile or both, Cables can comprise two or more wires running side by side, bonded, twisted, or braided together that form a single assembly. One end of the cable can be connected to a rotational device and the other left free for rotation.
- A great advantage of using cable for that rotational member 108 is that cable may undergo complex bends and are literally compliant, which allows them to be forgiving of misalignment. Also, when a cable passes around complex anatomy, bending stress in any single strand is far lower than in a rod or wire of the same diameter if exposed to the same bends. While cable for the transmission of rotational motions is used primary in low speed applications, use of polymer coatings or jackets would further reduce rotational friction and may be applicable for a higher speed. The most important feature of the cable-driven rotational motion is that a cable can bend in three dimensions. Such characteristics make cables very unique motion transmitters for endovascular and any other medical applications. Often, polymer strand(s) are used within cable structures such as Kevlar™ as an elastic backup.
-
FIGS. 4C-4D illustrate alternative configurations of the rotational member 108 including cables and multi wires.FIG. 4C shows a cable 402 attached to a rod, wire or tube 404 via attachment member 403, Such cables are usually made of metal or metals alloys, including but not limited to SST, Nitinol, Titanium, Silver, Copper, Inconel™ and others, with the addition of Kevlar™, Vectran™ and coated with PTFE, FEP, Nylon and other polymers. Several cable configurations maybe used for the current invention, including but not limited to 1×3 strand (one bundle with e wires), 1×7 strand (one bundle with seven wires), 3×7 strand (three bundle with 7 wire), 1×19 strand (one bundle with 19 wire), and many other combinations known in the art for industrial applications. The cable 402 is connected to the rod, wire or tube 404 via the connecting element 403 by bonding crimping, welding, soldering and other known methods. The cable 402 can also be directly attached to the rod, wire or tube 404 without an attaching element 403 using similar attachment methods. Also, the cable 402 may be a single element serving as an entire rotational member 108. There is a cap 405 attached to the distal end of the cable 402. The cap 405 can be formed using any of the configurations shown inFIGS. 3A-3H andFIGS. 4A-4B , and 5A-50 (described below). -
FIG. 4D shows astraight wire bundle 406 having two wires that are connected to a rod, wire or tube 408 via a connector 407. Such abundle 406 may include two or more straight wires, either connected to each other, partially connected to each other, or totally independent (i.e., not connected to each other). Thewire bundle 406 can be covered with a polymer sheath to provide a low-friction cover when needed. Acap 409 may be attached to the distal end of thewire bundle 406. The advantage of using a straight wire bundle on the distal end of the rotational member 108 is that a bending stress in any single wire is far lower than in a wire of the same diameter if exposed to the same bends. While the embodiment ofFIG. 4D does not belong to the categories of cables/strands, it can also be a very suitable and useful vehicle to deliver rotational motion around complex curves.Caps 405 and 409 may not always be required, and in such a case, a natural structure of the cable (FIG. 4C ) and two wires (FIG. 2D ) could serve as the distal tip of the rotational member. -
FIGS. 5A-5D illustrate alternative embodiments of thedistal portion 201 of the rotational member 108.FIG. 5A shows an arrow-shapedtip 300 positioned on thedistal tip 109 of the rotational member 108 and having atapered segment 500 proximally adjacent to thetip 300. Such a taperedportion 500 of the rotational member 108 can continue along the rotational member 108, or have a tapered or stepped transition into a larger or smaller size proximally. -
FIG. 5B shows a winged distal tip 302 positioned on thedistal tip 109 of the rotational member 108 and having a tapered segment 501 proximally adjacent to the tip 302. There is a secondary blade-shaped expanded section 400 located on the tapered portion 501 of the rotational member 108. The tapered portion 501 of the rotational member 108 may transition into acontinuous portion 502. The tapered portion 501 can also continue along the rotational member 108 or have a tapered or stepped transition into a larger or smaller size proximally. -
FIG. 5C shows a winged distal tip 302 located on thedistal tip 109 of the rotational member 108. The distal-most portion 503 of the rotational member 108 has a reverse taper. The immediate proximal portion 504 of the rotational member 108 has a conventional taper (smaller to larger) configuration. The tapered immediate proximal portion 504 of the rotational member 108 may transition into acontinuous portion 505. -
FIG. 5D shows a blade-likedistal tip 304 located on thedistal tip 109 of the rotational member 108. Thedistal-most portion 506 of the rotational member 108 has a tapered configuration. The secondary shape provides a blade-shaped expanded section 400 that is located on the taperedportion 506. The proximal segment 507 to the secondary blade 400 has a reverse taper that transitions into aconventional taper 508. The taperedportion 508 of the rotational member 108 may transition into a continuous portion 509, or continue as a taper along the rotational member 108, or have a tapered or stepped transition into a larger or smaller size proximally. - The combinations and numbers of the primary and secondary configurations that can be implemented on the
distal portion 201 of the rotational member 108 may vary. In one embodiment, there might be no primary shape at all, and one or more secondary shapes; in another embodiment, there might be one primary shape and no secondary shape; in yet another embodiment, there might one primary shape and one or more secondary shapes; and so on. -
FIG. 6A shows thedistal tip 109 of therotational member 109 in a flush position with thedistal end 106 of theaspiration catheter 105. -
FIG. 6B shows thedistal end 106 of theaspiration catheter 105 and thedistal portion 201 of the rotational member 108. The distance 600 between thedistal tip 109 of the rotational member 108 and thedistal end 106 of theaspiration catheter 105 when thedistal tip 109 is inside theaspiration catheter 105 can range between 0.0 mm and 50 mm, most preferably between 0.0 mm and 5 mm as measured using the fitting assembly 113 or any suitable visualization, intraoperative imaging, or other means. -
FIG. 6C shows thedistal end 106 of theaspiration catheter 105 and thedistal portion 201 of the rotational member 108. Thedistance 601 between thedistal tip 109 of the rotational member 108 and thedistal end 106 of theaspiration catheter 105 when thedistal tip 109 is inside theaspiration catheter 105 can range between 0.0 mm and 50 mm, most preferably between 0.0 mm and 5 mm as measured using any suitable visualization or intraoperative imaging, To simplify the positioning process, and to provide better visibility using any suitable visualization means, thedistal portion 201 of the rotational member 108 and thedistal end 106 of theaspiration catheter 105 can be made of radiopaque material. A radiopaque marker 112 can be positioned on thedistal end 106 of theaspiration catheter 105 and anotherradiopaque marker 200 can be positioned on thedistal end 201 of the rotational member 108. Often times, theaspiration catheter 105 will have to navigate a tortuous anatomy either within the endovascular system or outside the endovascular system, and the ability to position thedistal tip 109 of the rotational member 108 correctly inside thedistal end 106 of theaspiration catheter 105 may have a crucial impact on device safety and efficacy. -
FIG. 6D shows thedistal end 106 of theaspiration catheter 105 and thedistal tip 109 of the rotational member 108. Thedistal tip 109 of the rotational member 108 is positioned inside thedistal end 106 of theaspiration catheter 105. It is important that the radial gap 602 between thedistal tip 109 of the rotating rotational member 108 and the wall of the inner lumen 206 at thedistal end 106 of theaspiration catheter 105 is sufficient to not induce damages to the inner surface of theaspiration catheter 105. The gap 602 should be anywhere between 0.0 mm to 10 mm larger than the diameter of the internal lumen 206, with a preferred gap between 0.0 mm to 2 mm. - Adjustment of the
distances 600 and 601 plays a very important role in the safe and efficient removal of thromboembolic material. During removal of well-organized clots (chronic clots) for example, thedistal tip 109 of the rotational member 108 may be positioned outside thedistal end 106 of theaspiration catheter 105 to macerate or disintegrate clots or other material before the material reaches thedistal end 106 of theaspiration catheter 105, which is under vacuum during the thromboembolic material removal. Thus, this increases the system efficacy. In circumstances where procedural safety may be compromised, and exposure of thedistal tip 109 of the rotational member 108 outside thedistal end 106 of theaspiration catheter 105 might cause trauma or damage to the surrounding tissue, thedistal tip 109 of the rotational member 108 may be repositioned accordingly using the fitting assembly 113 and the distance marks on the tube 202 as described hereinabove inFIGS. 1 and 2 . The Touhy-Borst valve 204 may be positioned accordingly along the tube 202 to guarantee that thedistal tip 109 of the rotational member 108 is inside theaspiration catheter 105. Such positioning of the Touhy-Borst valve 204 using distance marks on the tube 202 may be performed in addition to observing the alignment of the radiopaque marker 112 at thedistal end 106 of theaspiration catheter 105 with thedistal tip 109 using fluoroscopy or any other appropriate visualization method. The fitting assembly 113 provides adjustment for thedistal tip 109 with respect to thedistal end 106 of theaspiration catheter 105, so thedistal tip 109 located inside theaspiration catheter 105 can be positioned therein so as to remain in contemporaneous position with thedistal end 106 of theaspiration catheter 105 if necessary. Theaspiration catheter 105 can be made of a polymer material and/or reinforced with a metal or polymer coiling, braiding and combinations of both, as well as including an internal lumen with a Teflon™ liner. -
FIG. 7A shows an example of a patient suffering from Ischemic Stroke having blood clots located in the Middle Cerebral Artery (MCA) 700. The MCA is one of the three major paired arteries that supply blood to the cerebrum and arises from the internal carotid artery. Blood clots located in the M1 segment (sphenoidal segment) are the most common situations for patients treated with medical devices. Such blood clots located in the cerebrovascular circulation is identified in the hospital by symptoms, CT scan, MRI or fluoroscopic evaluation. - After the location of blood clots is confirmed, the
aspiration catheter 105 is introduced to the cerebral vessel 700 and thetreatment site 701 in such a way that thedistal end 106 of theaspiration catheter 105 is in the vicinity of the blood clots to be removed. Introduction of theaspiration catheter 105 to thetreatment site 701 can be done using a support element. Use of support elements is well known in the medical device field and includes, but is not limited to, use of guidewires, dilators, additional catheters, guiding catheters or combinations thereof. InFIG. 7A , theaspiration catheter 105 is introduced to thetreatment site 701 operating in an over-the-wire approach using a conventional guidewire 702. Theaspiration catheter 105 can also have a rapid exchange guidewire feature, and may be introduced to the treatment area in a rapid exchange fashion, After positioning thedistal end 106 of theaspiration catheter 105 at the location of the blood clots, the guidewire 702 is removed. In the case where a rapid exchange guidewire is used, the guidewire may remain inside the body. Theaspiration catheter 105 can be positioned in the body using one of the following approaches: through femoral approach, brachial approach, surgical approach from any feasible location including patient neck, radial approach, antegrade to the blood flow, or retrograde to the blood flow approach. Theaspiration catheter 105 may be disconnected from the extraction device as shown inFIG. 2 or it may be any other suitable catheter that can access thetreatment site 701. - Referring to
FIG. 7B , after placing theaspiration catheter 105 in the cerebral artery 700 at theclot location 701 and removing the guidewire 702, the next step is to introduce the rotational member 108 of the extraction device 101 inside theaspiration catheter 105 such that thedistal tip 109 of the rotational member 108 is adjacent thedistal end 106 of theaspiration catheter 105, and within the catheter's distal-most end. After the rotational member 108 is positioned at thetreatment location 701, activation of aspiration and rotation of the rotational member 108 will follow to initiate the removal of blood clots outside the patient. The rotational member 108 rotates along its longitudinal axis at a speed between 100 to 200,000 RPM, and is configured to break blood clots and facilitate the aspiration of blood clots outside the patient. To facilitate the efficient removal of blood clots, thedistal end 106 of theaspiration catheter 105 can be repositioned relative to thedistal tip 109 of the rotational member 108 at any time before or during the removal of blood clots. It is desirable that thedistal tip 109 of the rotational member 108 remain in a contemporaneous position with thedistal end 106 of theaspiration catheter 105. Also, the distal end of the extraction device 101 may be repositioned back and forth accordingly to ensure that blood clots are removed effectively. While the removal of the guidewire 702 from theaspiration catheter 105 after its placement at theblood clot location 701 is mentioned above, the guidewire 702 can also remain in place at the treatment location at a position that will not interfere with the rotational member 108, In such circumstances, a physician/operator would have quick access to the guidewire 702 when and if needed. -
FIG. 7C shows a close-up view of thedistal end 106 of theaspiration catheter 105 and thedistal tip 109 of the rotational member 108 in the cerebral artery 700 atblood clot location 701 under aspiration, which is shown by thearrow 703. Thromboembolic material may be aspirated into theaspiration catheter 105 using a variety of aspiration modes, including but not limited to continuous aspiration, ON/OFF aspiration, modulated aspiration (Higher/Lower), or combinations thereof,FIG. 7C also shows an optional occlusion balloon 704 that provides at least a partial vessel seal around the area of thromboembolic material removal so as to minimize the aspiration of blood from neighboring vessels. The occlusion balloon 704 may be positioned proximal to thetreatment area 701 as shown inFIG. 7C , or it can be positioned distal to the treatment area (not shown), or occlusion balloons can be position distal and proximal to the treatment location 701 (not shown), To ensure a better positioning of the extraction device 101 at thetreatment location 701, theaspiration catheter 105 may have a smaller distal dimension than its proximal dimension. The removal of thromboembolic material may also include infusing the vessel or treatment site with fluid (e.g., sodium chloride, thrombolytic agent or therapeutic drug) to assist in the disintegration of, or to break up, the clot or tissue into a particle size that can then be more easily and quickly aspirated through a lumen of theaspiration catheter 105. Thrombolytic agents may include, but are not limited to: tissue plasminogen activator, blood clot reducing agents, antiplatelet agents, and other GIIb/IIIa inhibitors. - When the extraction device 101 is positioned at a treatment area with a complex access (such as cerebrovascular circulation) or in area with a simple access (such as AV fistula), the rotational member 108 traverses concomitant bends as the
aspiration catheter 105 during their introduction to the treatment area and during the removal of thromboembolic material. -
FIG. 8A is a close-up view of the aperture 117 located on the 3 way Y-connector 115, which is shown as having acircular opening 800.FIG. 8B shows theopening 800 closed using the operator's finger 801. Vacuum pressure pulsation can be achieved using any aperture within the extraction device 101 which normally is a well-sealed passageway structure between thedistal end 106 of the aspiration catheter 105 (inlet) and the outlet 120 of the vacuum pump 103 as shown inFIG. 1 , The operator can manually open and close theopening 800 using a finger. Opening and covering the opening 800 (ON/OFF) will produce pulsing vacuum pressure at thedistal end 106 of theaspiration catheter 105. The aperture 117 may have a regular opening configuration, including but not limited to, circular 800 (as shown), oval, square, rectangular, octagonal, hexagonal, or any non-regular configuration that can be conveniently covered by a finger. The ON or open time duration of the aperture 117 may be anywhere between 0.01 to 10 seconds. The OFF or closed time of the aperture 117 may also be in the same range of 0.01 to 10 seconds. Any combination of ON and OFF time is suitable for clot removal according to the present invention, -
FIG. 9A is a close-up view of the aperture 117 having alongitudinal incision opening 900. Vacuum pressure modulation at thedistal end 106 of theaspiration catheter 105 can be achieved in a similar way as the pulsation described above in connection withFIGS. 8A-8B . Different openings may be used for the aperture 117, including but not limited to: longitudinal incision 900 (as shown), slit or notch. Such incision opening 900 will allow the operator to move thefinger 901 along theopening 900 so as to increase or decrease the size of theopening 900 as shown inFIG. 9B , Increasing and decreasing finger coverage over theincision 900 will produce pressure modulation at thedistal end 106 of theaspiration catheter 105, and change compliance of the clots. The speed of the movement of thefinger 901 along theopening 900 depends on the desired aspiration modulation characteristics and may result in full opening and closure of theopening 900, partial opening and closure ofopening 900, and can also either be combined with ON/OFF pulsing. -
FIG. 10 is a close-up view of thedistal end 106 of theaspiration catheter 105 positioned at theclot location 1000, Arrows 1001 illustrate pulsation or modulation stress applied by the vacuum displayed byarrow 1002 from within thecatheter 105. Closing and opening the aperture 117 by the operator will cause ON/OFF stress on theclots 1000, weakening their structure by inducing fractures causing internal/external clot separation 1003, This illustrates the changing of the compliance of theclots 1000, thereby accelerating removal of the clots through theaspiration catheter 105 outside the patient. - Providing a saline flush during blood clot removal may greatly improve clot clearing by flushing clots to the blood container. Delivery of liquid during clot removal may be by achieved by flushing the extraction device 101, providing continuous flush distally to the clot removal area, or a combination of both.
- Use of negative suction pressures to achieve liquid transfer, air transfer or aspiration can be accomplished by a number of different methods depending on the mechanical pump design used. These pump designs can include piston pumps, diaphragm pumps, gear pumps or peristaltic pumps. In some liquid or air handling systems, pumps may utilize a pressurized reservoir to create the vacuum for further suction and collection of liquids. Other forms of liquid or air handling system utilize flow-through pumps and are considered stand-alone devices. From a clinical perspective, pumps for removal of clots, liquids or tissue from the human body using flow-through are considered single-use devices. Such pumps become contaminated after use and should be disposed of. Other pumps that utilize pressurized reservoirs can be reused and only suction collection containers need to be disposed of after a clinical procedure. The spirit of the present invention is not limited to use of a disposable suction pump or a reusable aspiration pump that utilizes suction containers, but can also include any other source of suction, such as a hospital's central aspiration system.
- While there are some physical limitations related to the operator's ability of opening or closing the aspiration aperture, or moving a finger along the incision at higher speed, simple electromechanical or electromagnetic devices can also be helpful to achieve a higher frequency pulsation and modulation.
- Alternatively, an additional aspiration source 1100 may be positioned over or around the
aspiration catheter 105 at a location within the distance x from thedistal end 106, shown inFIG. 11 . This distance x can be 1-10 cm from thedistal end 106 to further prevent dislodgement of small emboli 1102 from clot 1101, or distal movement or flooding into other vascular branches 1103 as shown inFIG. 11 . Such additional aspiration source 1100 can be a conventional guiding catheter 1104 or another catheter or sheath routinely used for such procedure, An external aspiration source (not shown) can be attached to the proximal outlet 1105 of theaspiration catheter 105, and the proximal outlet of the guiding catheter 1104. This dual-aspiration approach will assure that any emboli created during removal of blood clots will be further aspirated through the secondary aspiration source 1100. - Some embodiments of the present invention include cooling of brain tissue before, during or after the removal of thromboembolic material. For example, cooling brain tissue may involve local endovascular cooling, cooling the patient's neck, cooling the patient's head and/or cooling the patient's body.
- Elements or components shown with any embodiment herein are exemplary for the specific embodiment and may be used on or in combination with other embodiments disclosed herein. The invention is susceptible to various modifications and alternative forms and should not be limited to the particular forms or methods disclosed. To the contrary, the invention is to cover all modifications, equivalents and alternatives thereof.
- Some scientific and theoretical descriptions have been provided as the mechanism by which the devices and therapeutic methods are effective; these descriptions have been provided only for the purpose of conveying an understanding of the invention, and have no relevance to or bearing on claims made to this invention.
- Some theoretical considerations have been provided as to the mechanism by which these therapeutic methods are effective; these considerations have been provided only for the purpose of conveying an understanding of the invention, and have no relevance to or bearing on claims made to this invention.
- The scope of the claims appended hereto is not limited by any of the particular embodiments described below. For example, in any method or process disclosed herein, the acts or operations of the method or process may be performed in any suitable sequence and are not necessarily limited to any particular disclosed sequence.
Claims (21)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15/985,044 US20180263642A1 (en) | 2014-12-16 | 2018-05-21 | Methods and Devices for Removal of Thromboembolic Material |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462124406P | 2014-12-16 | 2014-12-16 | |
US14/668,622 US20160166265A1 (en) | 2014-12-16 | 2015-03-25 | Methods and Devices for Removal of Thromboembolic Material |
US14/682,893 US9943321B2 (en) | 2014-12-16 | 2015-04-09 | Methods and devices for removal of thromboembolic material |
US15/953,044 US20180242989A1 (en) | 2014-12-16 | 2018-04-13 | Methods and Devices for Removal of Thromboembolic Material |
US15/985,044 US20180263642A1 (en) | 2014-12-16 | 2018-05-21 | Methods and Devices for Removal of Thromboembolic Material |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/953,044 Continuation US20180242989A1 (en) | 2014-12-16 | 2018-04-13 | Methods and Devices for Removal of Thromboembolic Material |
Publications (1)
Publication Number | Publication Date |
---|---|
US20180263642A1 true US20180263642A1 (en) | 2018-09-20 |
Family
ID=56110024
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/682,893 Active 2036-03-29 US9943321B2 (en) | 2014-12-16 | 2015-04-09 | Methods and devices for removal of thromboembolic material |
US15/953,044 Abandoned US20180242989A1 (en) | 2014-12-16 | 2018-04-13 | Methods and Devices for Removal of Thromboembolic Material |
US15/985,044 Abandoned US20180263642A1 (en) | 2014-12-16 | 2018-05-21 | Methods and Devices for Removal of Thromboembolic Material |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/682,893 Active 2036-03-29 US9943321B2 (en) | 2014-12-16 | 2015-04-09 | Methods and devices for removal of thromboembolic material |
US15/953,044 Abandoned US20180242989A1 (en) | 2014-12-16 | 2018-04-13 | Methods and Devices for Removal of Thromboembolic Material |
Country Status (1)
Country | Link |
---|---|
US (3) | US9943321B2 (en) |
Cited By (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10251739B2 (en) | 2013-03-15 | 2019-04-09 | Insera Therapeutics, Inc. | Thrombus aspiration using an operator-selectable suction pattern |
USD847866S1 (en) | 2018-01-22 | 2019-05-07 | Insera Therapeutics, Inc. | Pump |
US10390926B2 (en) | 2013-07-29 | 2019-08-27 | Insera Therapeutics, Inc. | Aspiration devices and methods |
US10531883B1 (en) | 2018-07-20 | 2020-01-14 | Syntheon 2.0, LLC | Aspiration thrombectomy system and methods for thrombus removal with aspiration catheter |
US10653434B1 (en) | 2018-05-01 | 2020-05-19 | Imperative Care, Inc. | Devices and methods for removing obstructive material from an intravascular site |
US10653426B2 (en) | 2017-01-06 | 2020-05-19 | Incept, Llc | Thromboresistant coatings for aneurysm treatment devices |
US10960178B2 (en) | 2017-04-10 | 2021-03-30 | The Regents Of The University Of Michigan | Hydrodynamic vortex aspiration catheter |
US11065018B2 (en) | 2019-12-18 | 2021-07-20 | Imperative Care, Inc. | Methods and systems for advancing a catheter to a target site |
US11134859B2 (en) | 2019-10-15 | 2021-10-05 | Imperative Care, Inc. | Systems and methods for multivariate stroke detection |
US11147949B2 (en) | 2016-02-24 | 2021-10-19 | Incept, Llc | Method of making an enhanced flexibility neurovascular catheter |
US11207497B1 (en) | 2020-08-11 | 2021-12-28 | Imperative Care, Inc. | Catheter with enhanced tensile strength |
US11224458B2 (en) | 2017-04-10 | 2022-01-18 | The Regents Of The University Of Michigan | Hydrodynamic vortex aspiration catheter |
US11395665B2 (en) | 2018-05-01 | 2022-07-26 | Incept, Llc | Devices and methods for removing obstructive material, from an intravascular site |
US11439799B2 (en) | 2019-12-18 | 2022-09-13 | Imperative Care, Inc. | Split dilator aspiration system |
US11471582B2 (en) | 2018-07-06 | 2022-10-18 | Incept, Llc | Vacuum transfer tool for extendable catheter |
US11517335B2 (en) | 2018-07-06 | 2022-12-06 | Incept, Llc | Sealed neurovascular extendable catheter |
US11553935B2 (en) | 2019-12-18 | 2023-01-17 | Imperative Care, Inc. | Sterile field clot capture module for use in thrombectomy system |
US11565082B2 (en) | 2020-03-10 | 2023-01-31 | Imperative Care, Inc. | Enhanced flexibility neurovascular catheter |
US11766539B2 (en) | 2019-03-29 | 2023-09-26 | Incept, Llc | Enhanced flexibility neurovascular catheter |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9265512B2 (en) | 2013-12-23 | 2016-02-23 | Silk Road Medical, Inc. | Transcarotid neurovascular catheter |
US11547446B2 (en) | 2014-01-13 | 2023-01-10 | Trice Medical, Inc. | Fully integrated, disposable tissue visualization device |
US11065019B1 (en) | 2015-02-04 | 2021-07-20 | Route 92 Medical, Inc. | Aspiration catheter systems and methods of use |
CA2983072A1 (en) | 2015-02-04 | 2016-08-11 | Route 92 Medical, Inc. | Rapid aspiration thrombectomy system and method |
WO2017019563A1 (en) | 2015-07-24 | 2017-02-02 | Route 92 Medical, Inc. | Anchoring delivery system and methods |
CN109152584B (en) | 2016-03-17 | 2022-03-04 | 特里斯医疗有限公司 | Clot drainage and visualization devices and methods of use |
US10980555B2 (en) * | 2016-07-12 | 2021-04-20 | Cardioprolific Inc. | Methods and devices for clots and tissue removal |
WO2018132387A1 (en) | 2017-01-10 | 2018-07-19 | Route 92 Medical, Inc. | Aspiration catheter systems and methods of use |
EP3634265A1 (en) | 2017-05-23 | 2020-04-15 | Asahi Intecc Co., Ltd. | Assistive jet aspiration thrombectomy catheter and method of using same |
US20220104839A1 (en) | 2017-10-16 | 2022-04-07 | Retriever Medical, Inc. | Clot Removal Methods and Devices with Multiple Independently Controllable Elements |
CA3195810A1 (en) | 2017-10-16 | 2022-04-21 | Michael Bruce Horowitz | Clot removal methods and devices with multiple independently controllable elements |
US20190110804A1 (en) | 2017-10-16 | 2019-04-18 | Michael Bruce Horowitz | Catheter based retrieval device with proximal body having axial freedom of movement |
US11490908B2 (en) | 2017-11-09 | 2022-11-08 | Contego Medical , Inc. | Thrombectomy device and methods of use |
JP7150236B2 (en) * | 2018-01-29 | 2022-10-11 | 英博 山本 | surgical suction instrument |
EP3793660A2 (en) | 2018-05-17 | 2021-03-24 | Route 92 Medical, Inc. | Aspiration catheter systems and methods of use |
US11304713B2 (en) | 2018-09-07 | 2022-04-19 | Merit Medical Systems, Inc. | Thrombosis macerating and aspiration devices for blood vessels |
US11298506B2 (en) * | 2018-09-17 | 2022-04-12 | Stryker Corporation | Intra-ventricular infusion and evacuation catheter for treatment of intracerebral hemorrhage (ICH) |
US11272945B2 (en) | 2018-10-10 | 2022-03-15 | Innova Vascular, Inc. | Device for removing an embolus |
EP3917417A1 (en) | 2019-01-31 | 2021-12-08 | Merit Medical Systems, Inc. | Thrombosis macerating devices for blood vessels |
WO2021055603A2 (en) | 2019-09-18 | 2021-03-25 | Merit Medical Systems, Inc. | Torque cable |
CN110743087A (en) * | 2019-10-29 | 2020-02-04 | 吉林大学 | A peritoneal cavity drainage tube keeps somewhere equipment for blood tumour nursing |
US11717603B2 (en) | 2021-04-27 | 2023-08-08 | Contego Medical, Inc. | Thrombus aspiration system and methods for controlling blood loss |
EP4362828A2 (en) | 2021-06-28 | 2024-05-08 | Inquis Medical, Inc. | Apparatuses and methods for controlling removal of obstructive material |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5490859A (en) * | 1992-11-13 | 1996-02-13 | Scimed Life Systems, Inc. | Expandable intravascular occlusion material removal devices and methods of use |
US6022336A (en) * | 1996-05-20 | 2000-02-08 | Percusurge, Inc. | Catheter system for emboli containment |
US8236016B2 (en) * | 2007-10-22 | 2012-08-07 | Atheromed, Inc. | Atherectomy devices and methods |
-
2015
- 2015-04-09 US US14/682,893 patent/US9943321B2/en active Active
-
2018
- 2018-04-13 US US15/953,044 patent/US20180242989A1/en not_active Abandoned
- 2018-05-21 US US15/985,044 patent/US20180263642A1/en not_active Abandoned
Cited By (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11298144B2 (en) | 2013-03-15 | 2022-04-12 | Insera Therapeutics, Inc. | Thrombus aspiration facilitation systems |
US10251739B2 (en) | 2013-03-15 | 2019-04-09 | Insera Therapeutics, Inc. | Thrombus aspiration using an operator-selectable suction pattern |
US10463468B2 (en) | 2013-03-15 | 2019-11-05 | Insera Therapeutics, Inc. | Thrombus aspiration with different intensity levels |
US10335260B2 (en) | 2013-03-15 | 2019-07-02 | Insera Therapeutics, Inc. | Methods of treating a thrombus in a vein using cyclical aspiration patterns |
US10342655B2 (en) | 2013-03-15 | 2019-07-09 | Insera Therapeutics, Inc. | Methods of treating a thrombus in an artery using cyclical aspiration patterns |
US10390926B2 (en) | 2013-07-29 | 2019-08-27 | Insera Therapeutics, Inc. | Aspiration devices and methods |
US10751159B2 (en) | 2013-07-29 | 2020-08-25 | Insera Therapeutics, Inc. | Systems for aspirating thrombus during neurosurgical procedures |
US11147949B2 (en) | 2016-02-24 | 2021-10-19 | Incept, Llc | Method of making an enhanced flexibility neurovascular catheter |
US10653426B2 (en) | 2017-01-06 | 2020-05-19 | Incept, Llc | Thromboresistant coatings for aneurysm treatment devices |
US11224434B2 (en) | 2017-01-06 | 2022-01-18 | Incept, Llc | Thromboresistant coatings for aneurysm treatment devices |
US11903588B2 (en) | 2017-01-06 | 2024-02-20 | Incept, Llc | Thromboresistant coatings for aneurysm treatment devices |
US11931055B2 (en) | 2017-04-10 | 2024-03-19 | The Regents Of The University Of Michigan | Hydrodynamic vortex aspiration catheter |
US11224458B2 (en) | 2017-04-10 | 2022-01-18 | The Regents Of The University Of Michigan | Hydrodynamic vortex aspiration catheter |
US10960178B2 (en) | 2017-04-10 | 2021-03-30 | The Regents Of The University Of Michigan | Hydrodynamic vortex aspiration catheter |
USD847864S1 (en) | 2018-01-22 | 2019-05-07 | Insera Therapeutics, Inc. | Pump |
USD896847S1 (en) | 2018-01-22 | 2020-09-22 | Insera Therapeutics, Inc. | Pump |
USD847866S1 (en) | 2018-01-22 | 2019-05-07 | Insera Therapeutics, Inc. | Pump |
USD847865S1 (en) | 2018-01-22 | 2019-05-07 | Insera Therapeutics, Inc. | Pump |
USD850490S1 (en) | 2018-01-22 | 2019-06-04 | Insera Therapeutics, Inc | Pump |
US10835272B2 (en) | 2018-05-01 | 2020-11-17 | Incept, Llc | Devices and methods for removing obstructive material from an intravascular site |
US10653434B1 (en) | 2018-05-01 | 2020-05-19 | Imperative Care, Inc. | Devices and methods for removing obstructive material from an intravascular site |
US12042160B2 (en) | 2018-05-01 | 2024-07-23 | Incept, Llc | Catheter having angled tip |
US11123090B2 (en) | 2018-05-01 | 2021-09-21 | Incept, Llc | Neurovascular catheter having atraumatic angled tip |
US10786270B2 (en) | 2018-05-01 | 2020-09-29 | Imperative Care, Inc. | Neurovascular aspiration catheter with elliptical aspiration port |
US11311303B2 (en) | 2018-05-01 | 2022-04-26 | Incept, Llc | Enhanced flexibility neurovascular catheter with tensile support |
US11395665B2 (en) | 2018-05-01 | 2022-07-26 | Incept, Llc | Devices and methods for removing obstructive material, from an intravascular site |
US11471582B2 (en) | 2018-07-06 | 2022-10-18 | Incept, Llc | Vacuum transfer tool for extendable catheter |
US11850349B2 (en) | 2018-07-06 | 2023-12-26 | Incept, Llc | Vacuum transfer tool for extendable catheter |
US11517335B2 (en) | 2018-07-06 | 2022-12-06 | Incept, Llc | Sealed neurovascular extendable catheter |
US10722253B2 (en) | 2018-07-20 | 2020-07-28 | Syntheon 2.0, LLC | Aspiration thrombectomy system and methods for thrombus removal with aspiration catheter |
US10531883B1 (en) | 2018-07-20 | 2020-01-14 | Syntheon 2.0, LLC | Aspiration thrombectomy system and methods for thrombus removal with aspiration catheter |
US11406402B2 (en) | 2018-07-20 | 2022-08-09 | Rapidpulse, Inc. | Aspiration thrombectomy system and methods for thrombus removal with aspiration catheter |
US12004757B2 (en) | 2018-07-20 | 2024-06-11 | Rapidpulse, Inc. | Aspiration thrombectomy system and methods for thrombus removal with aspiration catheter |
US11547426B2 (en) | 2018-07-20 | 2023-01-10 | Rapidpulse, Inc. | Aspiration thrombectomy system and methods for thrombus removal with aspiration catheter |
US11918240B2 (en) | 2018-07-20 | 2024-03-05 | Rapidpulse, Inc. | Aspiration thrombectomy system and methods for thrombus removal with aspiration catheter |
US11766539B2 (en) | 2019-03-29 | 2023-09-26 | Incept, Llc | Enhanced flexibility neurovascular catheter |
US11504020B2 (en) | 2019-10-15 | 2022-11-22 | Imperative Care, Inc. | Systems and methods for multivariate stroke detection |
US11134859B2 (en) | 2019-10-15 | 2021-10-05 | Imperative Care, Inc. | Systems and methods for multivariate stroke detection |
US11633272B2 (en) | 2019-12-18 | 2023-04-25 | Imperative Care, Inc. | Manually rotatable thrombus engagement tool |
US11638637B2 (en) | 2019-12-18 | 2023-05-02 | Imperative Care, Inc. | Method of removing embolic material with thrombus engagement tool |
US11439799B2 (en) | 2019-12-18 | 2022-09-13 | Imperative Care, Inc. | Split dilator aspiration system |
US11819228B2 (en) | 2019-12-18 | 2023-11-21 | Imperative Care, Inc. | Methods and systems for treating a pulmonary embolism |
US11553935B2 (en) | 2019-12-18 | 2023-01-17 | Imperative Care, Inc. | Sterile field clot capture module for use in thrombectomy system |
US11065018B2 (en) | 2019-12-18 | 2021-07-20 | Imperative Care, Inc. | Methods and systems for advancing a catheter to a target site |
US11253277B2 (en) | 2019-12-18 | 2022-02-22 | Imperative Care, Inc. | Systems for accessing a central pulmonary artery |
US11457936B2 (en) | 2019-12-18 | 2022-10-04 | Imperative Care, Inc. | Catheter system for treating thromboembolic disease |
US11565082B2 (en) | 2020-03-10 | 2023-01-31 | Imperative Care, Inc. | Enhanced flexibility neurovascular catheter |
US11207497B1 (en) | 2020-08-11 | 2021-12-28 | Imperative Care, Inc. | Catheter with enhanced tensile strength |
Also Published As
Publication number | Publication date |
---|---|
US20180242989A1 (en) | 2018-08-30 |
US9943321B2 (en) | 2018-04-17 |
US20160166266A1 (en) | 2016-06-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20180263642A1 (en) | Methods and Devices for Removal of Thromboembolic Material | |
US20160166265A1 (en) | Methods and Devices for Removal of Thromboembolic Material | |
US10959750B2 (en) | Methods and devices for removing obstructing material from the human body | |
US11147949B2 (en) | Method of making an enhanced flexibility neurovascular catheter | |
US11471582B2 (en) | Vacuum transfer tool for extendable catheter | |
JP2022106867A (en) | Devices and methods for removing obstructive substance from intravascular site | |
US20220071647A1 (en) | Vascular Re-Entry Device | |
EP2395929A2 (en) | Neurovascular microcatheter device, system and methods for use thereof | |
WO1999060934A1 (en) | Medical device for the transportation and dissolution of fluid and matter from within the human body |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
AS | Assignment |
Owner name: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT, ILLINOIS Free format text: SECURITY INTEREST;ASSIGNOR:PENUMBRA, INC.;REEL/FRAME:052488/0785 Effective date: 20200424 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |
|
AS | Assignment |
Owner name: PENUMBRA, INC., CALIFORNIA Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT;REEL/FRAME:066596/0706 Effective date: 20240213 |